Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Purchase Now

An Unrivalled Speaker Line-up

Leadership Speakers

Cheryl MacDiarmid

Cheryl MacDiarmid

SVP and Business Unit Head US, Primary Care, GSK

Read more

Cheryl MacDiarmid is a member of the senior executive team in the US for GSK, a leading, multinational global pharmaceutical company. She is directly responsible for the US primary care sales division; strategy, planning and operations; and marketing, leading more than 2500 employees. A dynamic and strategic general manager, Cheryl brings 20 years of deep experience in building businesses in the US and Canada across sales, marketing and managed markets in both pharmaceuticals and vaccines.

She has a gift for creating and leading extraordinarily powerful teams. She seeks out and thrives on challenge, leading her teams to set an ambition, make choices and execute bold, game-changing moves that pivot and change a business trajectory. Notable recent accomplishments include catalyzing a significant turnaround within the US sales organization while solidifying a path to sustained growth and launching a new type 2 diabetes medicine in the US, exceeding external benchmarks and market expectations.

She is a values-driven leader with significant experience managing commercial risk, compliance and alliance governance. As a pharmacist, Cheryl navigates complex scientific and clinical data with ease and has a passion for respiratory disease and diabetes. She brings a global mindset to her work, having served as a chief of staff associate to the GSK President, International Region.

A native of Canada, Cheryl graduated from the University of Toronto with a degree in Pharmacy and subsequently received an MBA from the Schulich School of Business. She lives in Philadelphia. Her personal passions include running, skiing, and visits north to Canada.

Kabir Nath

Kabir Nath

President & CEO, Otsuka North America

Read more

Kabir is a senior commercial leader with more than 25 years of broad international biopharma and devices experience who has shaped strategy and delivered results in complex, challenging business environments at country, regional and global levels. He has lived and worked in the U.K., France, Spain, India, Singapore, China and the US.

Kabir joined Otsuka to head the North American pharmaceutical business in March 2016, with direct responsibility for Otsuka America Pharmaceuticals, Inc., Avanir and Otsuka Canada. Before joining Otsuka, Kabir spent 13 years in leadership roles at Bristol Myers Squibb. Most recently he was Senior Vice President, Virology, Transplant & Optimized Brands, responsible for the commercialization of a significant portfolio – including drugs for HIV, hepatitis B and hepatitis C and immunosuppression - in the USA.

Previously he was Senior Vice President, Global Commercialization - Virology & Neuroscience, leading global strategy for these two disease areas. In addition he served as interim head of Emerging Markets for much of 2012.

Kabir joined BMS in Singapore in 2003 as vice president for South East Asia/Taiwan/HK and moved to Shanghai in 2005 as president of BMS China. In 2008, Kabir was appointed president, Asia Pacific Medicines, with responsibility for all commercial operations in 13 countries. Prior to joining BMS, Kabir spent 11 years at Smith & Nephew, the medical technology company, in senior operational and strategic roles in the U.K., Europe and Asia. Kabir holds an MA from King’s College, University of Cambridge, and an MBA with Distinction from INSEAD.

Andy Schmeltz

Andy Schmeltz

Senior Vice President of Patient & Health Impact, Pfizer Innovative Health

Read more

More information coming soon...

Julie Gerberding

Julie Gerberding

Executive VP & Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health, Merck

Read more

Dr. Julie Gerberding is Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy, and Population Health at Merck & Co., Inc., where she also has responsibility for the “Merck for Mothers” global program to prevent maternal mortality and the Merck Foundation. She joined Merck in January 2010 as president of Merck Vaccines and led efforts to make the company’s vaccines more available and affordable to people in resource-limited countries around the world.

She left her tenured faculty position at the University of California, San Francisco in 1998 to lead the U.S. Centers for Disease Control and Prevention (CDC) Division of Healthcare Quality Promotion and then served as the CDC Director from 2002 to 2009. As director, she led the CDC through more than 40 emergency responses to public health crises, including anthrax bioterrorism, SARS, and natural disasters.  She also advised governments around the world on urgent issues such as pandemic preparedness, AIDS, antimicrobial resistance, tobacco, and cancer.

Dr. Gerberding currently serves on the Boards of CWRU, National Association of City and County Health Officials (NACCHO) Foundation, MSD Wellcome Trust Hilleman Laboratories, and the BIO Executive Committee.  She has received more than 50 awards and honors, including the United States Department of Health and Human Services (DHHS) Distinguished Service Award for her leadership in responses to anthrax bioterrorism and the September 11, 2001 attacks.  She was named to Forbes Magazine's 100 Most Powerful Women in the World in 2005 through 2008 and to TIME Magazine's 100 Most Influential People in the World in 2004.

Perry Sternberg

Perry Sternberg

EVP & Head U.S. Commercial, Shire

Read more

Perry joined Shire in 2013 and is head of Shire’s U.S. Commercial Organization. He is also a member of the Executive Committee.

Perry previously was Vice President & General Manager, U.S. & Canada Pharmaceuticals at Bausch & Lomb. Prior to that, he held various roles at Novartis Ophthalmics, Novartis Pharmaceuticals and Merck & Co., Inc.

Sheldon Koenig

Sheldon Koenig

SVP and Global Head Cardiovascular Franchise, Sanofi

Read more

Sheldon has a enjoyed a successful career of more than 25 years in various operations and marketing roles at Merck & Company and has now for the past year been with Sanofi Pharmaceuticals as Sr. VP and Head of the Cardiovascular Franchise. Sheldon has a broad range of experience in Cardiovascular marketing as well as developing product launch strategies in CV and infectious disease as well as several joint venture experiences and licensing agreements in several therapeutic areas. Sheldon received his MBA from Monmouth University and is undergraduate degree in accounting from Drexel University with post graduate and executive education studies completed at Wharton.

David Blair

David Blair

Head of Industry- Health, Google

Read more

David Blair is Head of Industry for Health at Google. He leads a team that provides thought leadership, digital marketing strategies, insights, and cross-platform advertising solutions utilizing Google’s search, content network, YouTube, mobile, programmatic and analytics platforms for the world’s leading pharmaceutical and consumer health companies. Prior to Google, David was General Manager/SVP of Provider Solutions at Everyday Health.

David began his digital career in 1997 at iVillage as Vice President of Strategic Sponsorships where he pioneered many of the first digital marketing initiatives with Fortune 500 companies including P&G, Coke, Ford, Kimberly Clark, Kellogg’s and Fuji Film. He moved into the digital health space in 2001 as SVP/Group Publisher for Johnson & Johnson’s BabyCenter.com and was SVP of Ad Sales for Revolution Health, before the merger with Everyday Health in 2008.

Blair serves on the Google Healthcare Advisory Board, was named one of the top 40 Healthcare Transformers in the US by Medical Marketing & Media in 2015 and was a juror for the 2016 Clio Health Awards. He is a frequent keynote speaker at major agencies and industry events, most recently the IMCAS World Congress; Cannes Lions Health, American Heart Association, and Cleveland Clinic’s Patient Experience Summit.

Melinda Richter

Melinda Richter

Head, Johnson & Johnson Innovation, JLABS

Read more

As Head of Johnson & Johnson Innovation JLABS, Melinda fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage. By providing infrastructure, services, educational programs and networks in global hotspots, JLABS is the best place to start a biotech company.

Prior to joining JLABS, Melinda was Founder and CEO of Prescience International, an award winning firm dedicated to accelerating research to the patient. Melinda founded Prescience after she had a medical emergency that left her questioning the efficiency and efficacy of the healthcare system. With the tenacity and resolve of a patient looking for a better solution, she set-out to create a better model, which now forms the basis for JLABS’ operational infrastructure. Prior to starting Prescience, Melinda held posts across a variety of functional areas with a global corporation, Nortel Networks, in locations such as Research Triangle Park, New York, Toronto, London, Hong Kong and Beijing before arriving in San Francisco. She also started, raised capital and did large corporate deals for several companies in both the life science and technology space. She holds a Bachelor of Commerce from the University of Saskatchewan in Canada and an MBA from INSEAD in France.

Marc Boutin

Marc Boutin

CEO, National Health Council

Read more

Marc Boutin is the chief executive officer of the National Health Council, the only organization that brings together all segments of the health community to provide a united voice for the more than 133 million people with chronic diseases and disabilities and their family caregivers.

Boutin has been a leading voice for greater patient involvement at every stage of the continuum, starting with the development of new drugs, to regulatory oversight of health care delivery, to shared decision-making at the point of care. Under his leadership, the NHC has convened a broad range of stakeholders to create and effectively implement pragmatic strategies and public policy that address diverse issues, such as enhancing patient engagement, advancing the development of new treatments, and developing a better health delivery system to meet the needs of people with chronic conditions.

Tolga Tanguler

Tolga Tanguler

Regional President, North America, Rare Disease, Pfizer

Read more

Tolga Tanguler is the Regional President, North America for Rare Diseases at Pfizer. In this role, Tolga sets forth an agenda that brings together the marketing, sales, corporate affairs and medical affairs teams to ensure they are focused on one objective: to transform patients’ lives. A key focus of the organization is to ensure that the engagement and experience of rare disease patients and their families is at the forefront of all programs.

Tolga has more than 17 years of experience in the global pharmaceutical industry, including leadership roles in both well-developed markets such as the US, Japan and the Nordics to emerging economies including Africa/Middle East and Latin America. Most recently, Tolga was the Vice President, Global Marketing for ELIQUIS. Throughout these various assignments, Tolga’s organizations were recognized for their strong growth trajectories and their colleague engagement programs.

Tolga has Bachelor of Science degrees in Economics & Finance from University of Istanbul, and a Masters of Business Administration in Marketing and Supply Chain from Michigan State University. He also has a Post Graduate Degree in Marketing from the University of California.

Andrew McCulloch

Andrew McCulloch

President, Kaiser Foundation Hospitals and Kaiser Permanente Health Plan of the Northwest

Read more

Since 2006, Andrew R. McCulloch has served as president of Kaiser Foundation Hospitals and Health Plan of the Northwest. Serving the states of Oregon and Washington, Kaiser Permanente provides medical care to over 550,000 members, along with a dental program serving over 250,000 members.

Under Andy’s leadership, Kaiser Permanente’s Northwest Region is consistently ranked as one of America’s highest performing health systems. Medicare has awarded the Northwest Region’s Medicare Advantage plan its coveted 5 Star rating for 5 consecutive years. The National Commission of Quality Assurance (NCQA) gave Kaiser Permanente Northwest’s Medicare and commercial plans the highest rating in the region in its most recent national survey results.

In the areas of customer service and community benefit, Kaiser Permanente is also recognized for its performance. In 2016— for the third year in a row — J.D. Power ranked Kaiser Permanente’s Health Plan #1 in customer satisfaction for Oregon and Washington. The Portland Business Journal has ranked Kaiser Permanente as #1 in corporate philanthropy for 2014 and 2015.

Andy received his B.A. from Wesleyan University and attended the University of Minnesota’s School of Public Health, where he received a master’s degree in Healthcare Administration. In 2015, Minnesota’s School of Public Health awarded Andy the Gaylord W. Anderson MD Leadership Award, recognizing his leadership in the field of public health. He is a Fellow of the American College of Healthcare Executives, which awarded him its Regent’s Award recognizing his contributions to the field of health care administration. In 2016, Andy was named as one of the Portland Business Journal’s top 10 ‘Executives of the Year’ for leading Kaiser Permanente Northwest’s membership growth while navigating Oregon’s health care industry.

Prior to joining Kaiser Permanente, Andy held increasingly responsible executive roles at the University of North Carolina Health Care System, UW Medicine, PeaceHealth, and Mercy Health.

Andy is also active in a number of professional and civic organizations. He has a special interest in health equity issues. He has served as a founding member of Health Share of Oregon, a coordinated care organization serving Oregon’s Medicaid population. In recognition of his leadership in transforming Oregon’s health care financing and delivery, the Oregon Business Association named him as their Statesman of the Year in 2012.

Andy and his wife, Sally, reside in Lake Oswego, Oregon.

Eddie Williams

Eddie Williams

Former SVP Biopharmaceuticals, Novo Nordisk

Read more
  • 36 years Pharmaceutical Industry experience
  • General Management Experience including P&L
  • 13+ Years of Specialty Biotech Experience
  • Bachelor’s degree in Biology/Chemistry from Marshall University
  • Advisory Board of National Sales Network
  • Chairperson of Capital Campaign of Boys & Girls Club of Trenton/Mercer for new facility
  • Board of Directors of Basic Supply Co., a small family-owned business of 35 years
  • Chair of National Hemophilia Foundation’s (NHF) Industry Advisory Panel
  • Board Member of BIO
  • Numerous internal Global Boards: Global Strategy and Commercial Boards (HSB & HCB), Global Marketing Board (GMB), Global Management Board (ManBoard), North American Executive Team (ET), Global Steering Committee for Business Development and Acquisitions
  • Executive Sponsor for Women in Novo Nordisk (WiNN)
  • Drove Franchise from $500m to $1.7B
  • All performance ratings of “Outstanding or Exceeds” by 6 different President/CEOs/SVPs over 13+ years
  • Market leadership in all 3 therapeutic areas
  • Drove 15+ year old product from 7% to > 50% share and #1 position in crowded 7-product commodity market
  • TBL: Chairperson of B&G Club fundraiser for new facility to raise $7.5M
  • Recognized as the Global “General Manager of the Year” at Novo Nordisk International GM Meeting
  • Awarded the “WE Upjohn Award“, the most prestigious global company performance award
  • Awarded “Lifetime Achievement Award“ by the National Sales Network
  • Recognized as “Industry Partner of the Year“ by National Hemophilia Foundation
  • Leadership Style and success highlighted in 2 published books by independent authors
Dalvir Gill

Dalvir Gill

CEO, Transcelerate BioPharma Inc.

Read more

Dr. Dalvir Gill currently serves as the Chief Executive Officer of TransCelerate BioPharma Inc., and its subsidiary, BioCelerate. TransCelerate is a non-profit organization with a mission to collaborate across the biopharmaceutical research and development community to identify, prioritize, design and facilitate the implementation of solutions to drive efficient, effective and high-quality delivery of new medicines, improving the health of people around the world.

Dr. Gill is a member of the TransCelerate Board of Directors, and spearheads a culture of collaboration amongst TransCelerate’s 19+ Member Companies, and an aggressive agenda that seeks to advance innovation in R&D, identify and solve common R&D challenges and further improve patient safety, with the goal of delivering more high quality medicines to patients.

Prior to his appointment as CEO of TransCelerate, he was the President of an international contract research organization. Dr. Gill earned his BSc in Applied Biology from the University of Hertfordshire and his PhD in Pathobiology from the Royal Free Hospital School of Medicine, University of London. He also holds a diploma in the Health Economics of Pharmaceuticals from the executive program of the Stockholm School of Economics. Dr. Gill has presented his research and spoken at numerous conferences, and has authored more than 30 scientific publications. He also is an elected fellow of the Royal Society of Medicine.

Patrick Desbiens

Patrick Desbiens

Senior Vice President US Vaccines, GSK

Read more

Patrick Desbiens leads GSK’s vaccines business in the US, bringing more than 25 years of industry insight. Patrick joined the US business in 2015 after serving as President of GSK France for nearly 3 years, overseeing the Pharma and Vaccines businesses and all GSK operations there. Previously he led the Sales & Marketing pharma teams in France and also served as General Manager for GSK Romania. A native French speaker from Montreal, Patrick started his career as a pharma rep with Eli Lilly-Canada before joining GSK Canada in 1996 where he worked across several functions in sales, marketing, communications, market access and public affairs.

Paul Darling

Paul Darling

Principle, ZS Associates

Read more

Paul Darling is a principal with ZS in the San Francisco office. Paul assists life sciences companies in evaluating new markets, acquisitions and licensing opportunities, as well as developing new go-to-market strategies. He has published and presented on these topics.

Paul leads ZS's institute on U.S. Healthcare Evolution and Scenario Planning. His work explores strategies for life sciences companies to take a broader role in patient health in the era of U.S. healthcare reform. This includes new business models, therapies, acquisitions, partnerships, and reimagining the commercial model to support such strategies.

Prior to joining ZS, Paul was a fellow at the Perelman School of Medicine at the University of Pennsylvania. He holds a B.S. in biochemistry from Boston College and a Ph.D. in statistical thermodynamics from Washington University.

Pratap Khedkar

Pratap Khedkar

Principle, ZS Associates

Read more

Pratap Khedkar is a managing principal in ZS’s Philadelphia office, and leads the firm’s global pharmaceuticals and data science practices. He has advised many biopharmaceutical and healthcare companies on a wide range of business issues including commercial strategy, customer-centric marketing, market access, sales compensation and advanced analytics.

A recognized healthcare industry expert, Pratap regularly contributes his insights to publications including The Wall Street Journal, Bloomberg Businessweek, Business Insider, Fortune, Medical Marketing & Media, NPR, Pharmaceutical Executive and others. Currently, his thought leadership work focuses on topics including healthcare policy; life sciences companies’ new commercial and organizational models; and the evolving relationships between patients, providers and payers, and the life sciences organizations that serve them.

Pratap holds a B.S. in computer science from the Indian Institute of Technology, Delhi, and a Ph.D. in computer science from the University of California at Berkeley.

Reagan Tully

Reagan Tully

VP, Strategy and Marketing, McKesson

Read more

Reagan Tully brings over 18 years of experience within the pharmaceutical industry in multiple therapeutic categories, including oncology, virology, vaccines, cardiovascular, respiratory and dermatology. She has led sales, operations, marketing and commercial strategy for multiple top 10 manufacturers, including products from clinical development through end of lifecycle. Currently she serves as VP of Strategy for McKesson Specialty Health, within a division that specializes in manufacturer solutions.

Customer Experience Speakers

Jonathan Barrett

Jonathan Barrett

VP Oncology Marketing, EMD Serono

Read more

Jon Barrett is the VP of Oncology Marketing for the US business at EMD Serono. He has worked in the Pharma industry for over 27 years, 21 of those years spent in Oncology. Jon is primarily focused on developing and implementing successful US launch strategies for the company’s oncology portfolio.

Prior to EMD Serono, Jon has worked at several oncology companies in Global, US and UK roles, including AZ, GSK, Sanofi and Eisai.

Jon grew up and was educated in the UK. He holds a BSc from the University of Southampton and lives with his family in Flemington, NJ.

David Fortanbary

David Fortanbary

Head of US Performance Training, UCB inc.

Read more

David has 30 years of Pharmaceutical and Biotech experience in a multitude of commercial roles in sales, sales leadership, marketing, market access, medical groups and learning and development.  Currently, David is the Head of Performance Training at UCB Pharmaceuticals, a global organization that is inspired by patients and driven by science.  In his role, David leads a team dedicated to bringing value to patients by enabling commercial teams to effectively engage with stakeholders who are a part of the patients’ journey in serious neurological and immunological diseases.  David is also the current Vice-President of LTEN – a Life Science Trainers and Educators Network.

Jay Graves

Jay Graves

Vice President of Sales, Roche Diabetes Care

Read more

Jay is responsible for leading the U.S Professional Sales organization to include, the HCP Sales Force, Inside Sales, Global Pharma Trials, Sales Training, and Operations. Since joining Roche in 2006, Jay has held several positions within Diabetes Care to include Physician Field Sales Representative, Region Business Manager – Health Care Provider, Region Business Manager – Managed Care, Retail and Distribution, Area Business Director for the Central and Western US and Region Marketing Director for Blood Glucose Portfolio.

Jay began his professional career in 1998 as an Intelligence Officer in the United States Army. In the Army, Jay held multiple leadership positions and global deployments including tours in South America, Central America, The Caribbean, South Korea, The United Kingdom, Jordan and Iraq. After leaving the Army, Jay worked as a Field Sales Representative in Sanofi-Aventis’ Metabolism Division before moving to Roche Diabetes Care.

A native of Raleigh, N.C., Jay earned a bachelor’s degree in Political Science and Military Science from North Carolina State University and is currently enrolled in the Executive MBA program at the University of North Carolina at Chapel Hill.

Kasia Hein-Peters

Kasia Hein-Peters

Vaxelis (PR51) Marketing Head, Sanofi Pasteur

Read more

Trained as medical doctor, innovation consultant and executive coach, Kasia Hein-Peters, MD has more than 20 years of experience in pharmaceutical industry, in both developed and emerging markets. She specializes in launching new medicines and vaccines, managing product life-cycle, and developing integrated stakeholder engagement campaigns. Through mentoring and coaching, Kasia builds highly performing, diverse teams. She likes speaking on global brand management, multicultural marketing and human-centric approach in pharma marketing. Currently, Kasia is preparing launch of a new hexavalent vaccine as a Marketing Head of MCM Vaccine, a joint-venture between Sanofi Pasteur and Merck & Co., Inc./MSD.

John Jacoppi

John Jacoppi

Executive Director- Marketing, Sunovion

Read more

John Jacoppi is Executive Director, New Products Planning at Sunovion Pharmaceuticals, Inc. He recently served as Executive Director, Psychiatry Marketing, where he launched a comprehensive DTC campaign in support of Latuda®. He brings over 27 years of pharmaceutical experience and has worked at Johnson & Johnson and Astra Zeneca in various roles. John brings a wealth of successful commercial experiences including positioning, segmentation, customer loyalty, patient-centricity and a full range of marketing/life cycle management activities. He holds a Bachelor of Arts Degree from University of Pennsylvania and a Masters in Management from Northwestern University's Kellogg School of Management.

Kobi Gershoni

Kobi Gershoni

Co-Founder & Chief Research Officer, Signals

Read more

Prior to co-founding Signals, Kobi was a Senior Analyst and Information Officer for an elite intelligence unit in the Israel Defense Forces, where he began to contemplate and refine the incorporation of open source intelligence into the growth plans of consumer brands and innovation agendas of life sciences companies. Kobi holds an MBA in Finance and Strategy as well as a BA in International Relations from Hebrew University in Jerusalem.

Mike Gianelli

Mike Gianelli

Director, Acquia

Read more

Michael Gianelli is the Director of Acquia's Healthcare practice. He has helped organizations like J&J, Roche, and Novartis transform their approach to digital to meet the ever changing needs of patients, doctors and healthcare providers. 

Heidi Floyd

Heidi Floyd

Author/Patient/Advocate/Speaker

Read more

As individuals are diagnosed with cancer, many immediately seek to make a connection with others for help.  Heidi Floyd has become that resource for many. As an author/speaker/patient/advocate, she is able to lean on myriad of NGOs and fellow patients in her network. Heidi has the ability to lean in and listen to true needs – from caregivers and corporations who want to help, but aren’t sure where to begin. Connecting those who need with those who can assist is her true passion, and has done so worldwide. She’s addressed venues as varied as Google to classrooms of 6.

Jim Demaioribus

Jim DeMaioribus

Vice President, Marketing, Aqua Pharmaceuticals

Read more

Jim DeMaioribus is Vice President of Marketing at Aqua Pharmaceuticals, an Almirall Company. While many are awakening to social media, Jim has helped businesses capitalize on the opportunities created through this unique and diverse medium for nearly a decade.

Jim has had significant success in identifying new business opportunities across 200 companies where technology can serve as a new revenue generating opportunity or to add value to an existing product portfolio.

José Ignacio Rasco

José Ignacio Rasco

CEO, .health

Read more

José Ignacio Rasco is the Chief Executive Officer and founder of dotHealth, where he is responsible for the company’s vision, strategy and growth. Previously, José Ignacio was a co-founder and the Chief Financial Officer for the .CO registry. As part of the .CO team, José Ignacio helped grow the registry from 30,000 to 1,000,000+ domains in less than one year. Today, .CO is a mainstream domain with 2,000,000+ domains registered. He and his co-founders sold .CO in 2014 to Neustar, a public company and the largest provider of core registry and digital naming services. José Ignacio also serves as Managing Director of STRAAT, a Miami-based company that builds innovative companies including BUILDING.co and Classic.com.

Prior to José Ignacio's work in the registry and domain business, he worked in public accounting with varied industry experiences in audit and assurance services. He is a Certified Public Accountant in the State of Florida and holds a Bachelors of Science degree in economics from the Wharton School of the University of Pennsylvania and a Master’s degree in taxation from Florida International University.

Ed Chase

Ed Chase

Business Line Leader, Life Sciences, Pegasystems

Read more

More information coming soon...

Ashkan Afkhami

Ashkan Afkhami

VP & GM, Healthcare, Mobiquity

Read more

More information coming soon...

Mike Welsh

Mike Welsh

Chief Creative Officer, Mobiquity

Read more

More information coming soon...

Patients as Partners Speakers

Anthony Yanni

Anthony Yanni

Global Head, Medical Intelligence and Patient Perspectives, Sanofi

Read more

Anthony J. Yanni, MD, MBA currently serves as Head, Medical Intelligence and Patient Perspectives for Sanofi Global R&D. Dr. Yanni is a graduate of Drexel University School of Medicine in Philadelphia, Pennsylvania and received an MBA from the University of Massachusetts. He completed a 3 year Residency in Internal Medicine for which he was Board Certified in 1995 and recertified in 2005. Following his specialty training, Dr. Yanni practiced clinical medicine for 12 years and while in practice served as Chief, Internal Medicine at a hospital system in Pennsylvania. He later served as Chief Medical Officer in the same system.

After leaving clinical practice, Dr. Yanni began his career in the pharmaceutical industry with Sanofi Pasteur, working as a Director, Clinical Development where he managed the development of protocols and execution of clinical trials for vaccines. He also worked with teams in the evaluation of external opportunities. From Sanofi Pasteur, Dr. Yanni moved to Sanofi where he served as Senior Director, Translational Medicine and Clinical Development where he focused on the identification of Medical Value and Patient Need in targeted indications. He began his current role, Global Head, Medical Intelligence and Patient Perspectives in 2013.

While at Sanofi, Dr. Yanni co-led the development of the Patient Engagement Portal and continues to lead R&D efforts in developing and operationalizing meaningful patient engagement in research.

Kate Gordon

Kate Gordon

Policy Advisor, Alzheimer’s Disease International

Read more

Kate Gordon is a Policy Adviser for Alzheimer’s Disease International where she provides public policy and campaign guidance, focusing on work with the Pan American Health Organization.She is a skilled health policy analyst and grassroots advocacy strategist with more than 15 years of experience working in the fields of health and long term care. Her expertise includes policies affecting persons with dementia, caregiver interventions, and direct care worker training. Kate’s previous work includes collaborating with multiple federal entities and state and community-based agencies to connect older adults with easy, actionable opportunities for clinical trial research participation.

Kate Zhong

Kate Zhong

Chief Strategy Officer, Global Alzheimer’s Platform

Read more

Dr. Kate Zhong is the Chief Strategy Officer for the Global Alzheimer’s Platform (GAP), a foundation devoted to improving and accelerating clinical trials for Alzheimer’s disease. Dr. Zhong leads the organization’s strategic planning, marketing and branding effort, patient recruitment and engagement, technology development and alliance.

Prior to this role, Dr. Zhong was the Senior Director of Clinical Research and Development for the Cleveland Clinic Lou Ruvo Center for Brain Health, which has been established as one of the largest and most active clinical trial facilities for memory disorders in the country; with more than 60 drugs and diagnostic trials being conducted at the Center.

Dr. Zhong received her MD degree from West China University of Medical Sciences in Sichuan, China. She earned her Master Degree in Pharmacology and completed her residency in Psychiatry at University of Toronto, Canada. As a Geriatric Psychiatrist, Dr. Zhong has extensive experience in providing treatment and care for patients with neurocognitive disorders. While working as the Medical Director and Seroquel Brand Global Physician for one the world’s leading pharmaceutical companies, Dr. Zhong led multiple global clinical trials in CNS therapeutic areas including Alzheimer’s disease, Parkinson’s disease, schizophrenia, and mood disorders.

Dr. Zhong has been a scientific consultant for multiple pharmaceutical, biotech, and patient recruitment companies. Dr. Zhong has provided multifaceted services to industry, academic centers, and health care institutions in the United States, Canada, and Asia. Dr. Zhong works closely with patient advocacy groups, philanthropic organizations, private foundations, and technology companies. She is actively engaged in public education and community activities involving clinical research, healthy aging, and brain wellness.

She serves as one of the founding members of WomenAgainstAlzheimer’s and is a member of International Women’s Forum. She was honored as a “Woman to Watch” and” Alzheimer’s Ambassador” by Vegas Inc. Magazine. She was featured in the PBS documentary “MAKERS: Women Who Make America,” profiling her as one of Nevada’s most influential women. She was recently honored with the Las Vegas Top Tech Exec Award and Healthcare Headliner Research Award for her creation of Cleveland Clinic healthybrains.org, an innovative interactive digital platform to accelerate clinical trial enrollment and to engage the community to become involved with a brain healthy life style.

Teresa Bitetti

Teresa Bitetti

SVP, Head US Oncology, Bristol-Myers Squibb

Read more

Teresa Bitetti is the Senior Vice President and Head of U.S. Oncology at Bristol-Myers Squibb. In this role, she leads the strategy and commercial operations for the U.S. Oncology organization. Under her leadership, Bristol Myers Squibb Immuno-Oncology agents in the U.S. Market has grown exponentially with the launch of two new drugs, Opdivo and Empliciti, increasing the Oncology portfolio to 11 indications across 6 tumor types in less than three years. She strives for excellence in commercial execution, and encourages her teams to deliver multi-pronged, innovative approaches to reach patients.

Prior to this appointment, Teresa was the President and General Manager of Bristol-Myers Squibb Canada where she was responsible for commercial operations across the entire portfolio.

Ms. Bitetti joined Bristol-Myers Squibb in 1996 and has successfully led teams across multiple therapeutic areas and functions. Some of her key leadership roles include, Vice President, Virology, Global Commercialization; Vice President, Neuroscience National Sales; Vice President, Neuroscience Marketing; and Regional Vice President for the Northeast Sales Region.

Prior to joining Bristol-Myers Squibb, Teresa held various roles of increasing responsibility at Mobil Oil Corporation where she was part of the Capital Markets Group and was responsible for the investment of Mobil's worldwide pension assets.

Over Teresa’s 20 year career, she has been highly recognized for her adept ability to mobilize teams to deliver exceptional performance. Her notable awards include Medical Marketing Association 2003 Pharmaceutical Marketer of the Year Award and Medical Marketing & Media 2016 Hall of Femme Honoree.

Teresa holds a BA in Classical Civilization from Wellesley College and an MBA in Finance from Darden School of Business at University of Virginia.

Paul Harney

Paul Harney

Vice President, Solutions Design, North America, Integrated Engagement Services, Quintiles IMS

Read more

Paul Harney has joined QuintilesIMS as Vice President, Solutions Design, North America, Integrated Engagement Services. For more than 18 years, Paul has served the healthcare and life sciences industry with advice, guidance, and business support. He has engaged biopharmaceutical companies in nearly all functional areas including Sales, Marketing, Medical Affairs, Business Development, and Supply Chain. Paul draws on specific expertise in strategy, communications, operations, and analytics at the brand/franchise, division, and corporate levels to identify opportunities to increase value. His extensive experience with retail and institutional products covering several therapy areas such asdiabetes, respiratory, anti-infectives, urology, vaccines, and dermatology allows him to quickly leverage best practices and initiatives that enhance go-to-market strategies.

MarlaJan Wexler

MarlaJan Wexler

Patient, Lupus Advocate and Blogger, Luck Fupus

Read more

MarlaJan Wexler is 35 years old, was born with a complex congenital heart defect, and had 4 open-heart surgeries by the time she was 6. She went from pediatric cardiac ICU patient to pediatric cardiac ICU nurse until being diagnosed with systemic lupus erythematous (lupus). Due to complications from the disease, she was forced her to give up her nursing career. Since 2008 she has been diagnosed with lupus and multiple overlapping autoimmune diseases, cervical cancer, and underwent a double mastectomy December 2014 after a lump was found in her breast.

She’s the creator and author of the blog Luck Fupus (www.luckfupus.com) which she writes about the day-to-day and long-term struggles of living with multiple chronic illnesses. She’s know for her humorous, non-sugar coated, keep-it-real style of writing. Her blog was used as a platform to help her become a patient leader and influencer, and she now travels the country attending healthcare conferences, speaking publicly sharing her story, educating and advocating for patients across the globe.

Email - luckfupusblog@gmail.com
Blog - Luck Lupus www.luckfupus.com
Twitter - @marlajan
Facebook - www.facebook.com/luckfupusblog
Instagram - @marlajan
Pinterest - marlajan81

Jeffrey Rohwer

Jeffrey Rohwer

Co-Founder, Sentient

Read more

More information coming soon...

Anthony (Tony) J Schueth

Anthony (Tony) J Schueth

CEO & Managing Partner, Point-of-Care Partners

Read more

Anthony Schueth, MS, is the CEO and Managing Partner of Point-of-Care Partners (POCP), a health information technology (HIT) strategy and management consulting firm specializing in the evolving world of electronic health records. A 25-year healthcare veteran, he is an expert in HIT, in general, and one of the nation’s foremost experts in ePrescribing and eMedication Management. In addition, he previously served as a co-leader of NCPDP’ Specialty ePrescribing Task Group and leads the NCPDP Electronic Prior Authorization Task Group. Mr. Schueth has led numerous transformative industry initiatives, including the highly successful Southeastern Michigan (SEMI) ePrescribing Initiative.

Digital Transformation

Nicole Mowad-Nassar

Nicole Mowad-Nassar

Vice President External Partnerships, Takeda

Read more

Nicole Mowad-Nassar is the Vice President of External Partnerships at Takeda Pharmaceuticals, a leading international pharmaceutical company. Her years of commercial experience span multiple key responsibilities in sales and marketing, as well as operations and analytics. An accomplished general manager who has successfully overseen integrated functions, Nicole possesses core competencies that include proven alliance management expertise. She leverages her broad understanding of the pharmaceutical industry to best identify opportunities in Takeda’s business to enhance the patient journey and answer key clinical questions via big data and digital innovations.

As Vice President of External Partnerships, Nicole is pioneering the company’s efforts to pursue innovative and game-changing technology collaborations. She is charged with identifying the linkages between the healthcare/pharmaceutical and technology sectors. Her extensive background in the pharmaceutical industry has proven essential in this capacity - knowledge of healthcare procedures and best practices is vital in order to improve relationships between patients, technology entrepreneurs and healthcare providers.

Nicole Mowad-Nassar has more than 20 years of experience in the pharmaceutical industry. Prior to joining Takeda, Nicole served as Divisional Vice President and General Manager, U.S. Primary Care Sales and Marketing for Abbott Laboratories. In that capacity, she led a team of over 2,500 sales and marketing professionals and gained acquisition integration experience. While at Abbott, she also held several Vice President and general management positions in a number of therapeutic areas of both hospital products and pharmaceuticals. Nicole also brings sales and marketing experience from TAP Pharmaceuticals, a former joint venture between Takeda and Abbott.

During her tenure with Takeda, Nicole Mowad-Nassar has launched over 11 products in recent years and accepted a leadership role as a member on several steering committees dedicated to developing partnerships between Takeda and other companies. Nicole was distinguished as an Emerging Leader by Pharmaceutical Executive in 2011, and she received the Takeda Global Award in 2010 in recognition of her outstanding achievements at Takeda. In 2005, she was named an HBA Rising Star.

Laura Barry

Laura Barry

Senior Director Customer Insights, Analytics and Experiences, AbbVie

Read more

Laura Barry is Senior Director, U.S. Insights, Analytics and Customer Experiences. She is responsible for Marketing Operations encompassing Digital, CRM, Media, Promotional Operations, Marketing Training, as well as Marketing Analytics and Business Insights for U.S. Commercial which represents 62% of the $25.6 Billion AbbVie Inc. Laura is fairly new to Pharma, and joined Abbott, now AbbVie prior to the split in February, 2012.

Laura joined AbbVie five years ago to lead the Market Analytics and Business Insights team. Laura has been a key leader in driving AbbVies’ Consumer Centricity and developing core capabilities in insight discovery, patient journey, comprehensive analytics and influencing AbbVies’ business optimization. Over the past five years her responsibilities have expanded to include Marketing Operations where she has set out key initiatives in Digital Transformation in partnership with line businesses in creating connected customer experiences.

Prior to AbbVie, Laura spent a rewarding 21 year career at Kraft Foods. Most recently she held position of Vice President, Shopper Insights and Category Leadership, Kraft, North America. Prior to this position, Laura was Vice President, Consumer Insights and Strategy, Kraft, North America. Laura is a committed member of the marketing community and a member of Rutgers MRIA Board, IMS Strategic Board, MSI Trustee, and HBA.

Mark Baglin

Mark Baglin

Vice President of Global Marketing, Alnylam Pharmaceuticals

Read more

Mark has been Vice President, Global Marketing for Alnylam Pharmaceuticals, based in Cambridge, MA, since February 2017. Originally from the UK, he has over 25 years’ commercial and franchise leadership experience within global healthcare organizations, living for the last 20 years in the US. He has successfully built teams and delivered results for global and US companies in Pharmaceutical, Biotechnology and Medical Device spaces in both pre- and post-launch environments. Before joining Alnylam, Mark had held positions of increasing seniority within GSK, AstraZeneca, Johnson and Johnson and, most recently, Shire Pharmaceuticals where, as Vice President, Product Strategy Team Leader, he was responsible for building a $1bn+ portfolio of products in the Hereditary Angioedema rare disease space. When not working, Mark enjoys keeping fit and running around after his family. Not unrelatedly, he also enjoys climbing into caves, jumping from airplanes and riding dangerous motorcycles.

David Lennon

David Lennon

VP & Franchise Head – US Oncology, Novartis

Read more

Dave is the VP & Head, Oncology Solid Tumors Franchise in Novartis’ US Oncology. He joined Novartis Pharmaceuticals in 2005 based in Basel, Switzerland as Head of New Products and Portfolio Strategy and later Global Business Franchise Head of Immunology and Infectious Diseases. He has assumed positions of increasing commercial responsibility, most recently spending 3 years in Shanghai, China, as Chief Marketing Officer and Head, Cardio-Metabolic Business Unit.

Prior to joining Novartis, Dave’s work focused on pharmaceutical R&D Strategy, M&A and business development at McKinsey & Company rising to Associate Principal.

Dave attended Columbia College as an I.I. Rabi Scholar majoring in Biophysics. In 2001, he completed his PhD at Weill Medical College.

Christopher Pitcherella

Christopher Pitcherella

Director, Clinical Trial Innovation | Global Clinical Operations, Teva

Read more

Chris is currently the Director of Clinical Trial Innovation within the Teva’s Global Clinical Operations organization sitting within the Global Specialty Development division of Teva. Chris’ main accountabilities are being a key driver, influencer, and accelerator of clinical trial innovation opportunities. Chris provides focused efforts on leading transformational opportunities regarding the use of healthcare data and technologies that offer novel approaches to clinical trial design, feasibility, recruitment, trial operations, site and patient centricity, quality oversight, and overall execution of clinical trial programs. Chris has over 17 years of experience in pharmaceutical development, progressing through diverse roles of increasing responsibility in the areas of clinical operations; strategic sourcing & procurement; project management; and alliance management. Chris has a BS in Business Marketing and an MBA with a concentration in Management Information Systems from Stockton University, as well as an MS in Clinical Research Organization and Management from Drexel University.

Joshua Palau

Joshua Palau

Sr. Director Digital Innovation, Social Media and Search, Johnson & Johnson

Read more

Joshua is the Sr. Director of Global Partnerships for Johnson & Johnson’s Global Marketing Solutions group. In this role he leads the global partnerships with Google, facebook, and creative agencies to ensure brands are effectively leveraging these platforms and deliver the best experiences. Prior to J&J, Joshua spent 4 years as the VP of Marketing and e-commerce for Comcast and 6 years at Razorfish as the VP of Search Marketing.

In his spare time, he’s an adjunct professor at Temple University, serves as an advisor for the AdCouncil and volunteers for The St. Baldrick’s Foundation whose focus is funding research for childhood cancers.

Joyce Ercolino

Joyce Ercolino

Digital Business Leader & Strategist

Read more

Joyce Ercolino was formerly Head of Digital Communications at CSL Behring, where she led the enterprise to embrace digital transformation and customer experience excellence. Joyce established and matured digital marketing and social media across CSL through advocacy, education and tenacity.

As Director of eStrategy in Global Commercial Development, she was responsible for digital and social media strategy, and established and chaired two global cross-functional teams to support compliance and knowledge sharing.

Joyce combines marketing and technology expertise to deliver patient and product marketing programs. She shares her passion for digital healthcare to create meaningful relationships with customers.

Bob Cannon

Bob Cannon

Chairman and CEO, Eagle Productivity Solutions

Read more

Bob Cannan is CEO of Eagle Productivity Solutions, the leading provider of training and business process solutions for the pharmaceutical industry. Eagle has offices in the U.S., the U.K. and Spain, and has delivered effective training in more than 40 countries and 20 languages.

Bob subscribes to Steve Jobs’ philosophy that, "Man is the creator of change in this world. As such he should be above systems and structures, and not subordinate to them.”

For more than 20 years, Eagle has been helping companies remain “above” systems and structures, evolving with their tools instead of falling subordinate to them. As tools and technology continue to change, Eagle’s high-adoption training helps companies keep up.

David Reim

David Reim

Chief Product Officer, DMD

Read more

David Reim invented the Internet in 1993. In 1995 he led the team that launched www.Claritin.com, the first branded pharmaceutical website. He followed that with several decades of wandering around the new rain forest of digital marketing, accompanied by a troop of hairless albinos. Now he finds himself at EyeForPharma. No one is as surprised as him.

Will Reese

Will Reese

President Cadient & Chief Innovation Officer, Cognizant Life Sciences

Read more

Will Reese leads the creative and innovation teams in identify emerging trends and crafting customer experiences. Will is a frequent speaker and writer on the healthcare customer experience, content marketing, and digital disruption. Will brings more than 17 years of healthcare industry experience, providing strategy, user experience, and creative consulting for major healthcare, life science, OTC, medical device, and biotech clients. He has worked across a wide variety of therapy areas including women’s health, oncology, cardiovascular, and neuroscience. His industry expertise has led him to develop award-winning programs and first of their kind experiences for industry leading clients and brands. Will has extensive experience in innovation consulting, launching new products, integrating emerging technologies, and designing new approaches to the commercial model.

Patrick Richard

Patrick Richard

Managing Director Data Science, inVentiv Health Communications

Read more

As Managing Director of Data Science for inVentiv Health Communications, Patrick partners with agency teams to build and implement unique offerings in the predictive analytics, strategic planning, and measurement space. Patrick’s experience building award-winning marketing platforms for some of the world’s most recognized companies and his diverse background in retail, e-commerce, travel, consumer, and healthcare allow him to bring diverse expertise and strategic guidance to business challenges. Prior to inVentiv Health Communications, Patrick developed digital platform strategies that defined effective ways to approach the digital consumer experience for companies such as Orbitz.com and Sears Holdings Online Services.

Leigh Householder

Leigh Householder

Managing Director of Innovation, inVentiv Health Communications

Read more

As Managing Director of Innovation for inVentiv Health Communications, Leigh is responsible for shaping the company’s perspective on the next era of healthcare marketing. Through thought leadership, strategic innovation workshops and new products and capabilities, Leigh focuses on identifying marketing approaches that will fuel that new era and generate significant growth for clients. Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for nearly two decades, and has worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Every year, Leigh convenes a group of trend watchers from across inVentiv Health’s global network to identify the shifts most critical to healthcare marketers.

Robert Palmer

Robert Palmer

EVP, Managing Director, Juice Pharma Worldwide

Read more

Robert Palmer is EVP, Managing Director at Juice Pharma Worldwide. He has over 15 years of DTC and HCP pharmaceutical experience. Before joining Juice Pharma in 2010, Robert was Managing Partner at Sudler & Hennessey, overseeing Sudler’s digital practice. Prior experience includes Managing Director of Tribal DDB New York, where he founded Tribal’s healthcare practice with the online DTC consumer launch of AbbVie’s blockbuster HUMIRA. He has also been a Partner at Rosetta, where he specialized in attitudinal segmentation and CRM. Robert is presently on the Advisory Board of the Digital Health Coalition, a member of the Programmatic Health Coalition, and is Chairman of the Medical Advertising Hall of Fame.

Matt Kollmorgen

Matt Kollmorgen

Vice President of Digital Transformation Group, Soft Serve

Read more

Matt Kollmorgen is a Vice President in SoftServe’s Digital Transformation Group, focused on helping companies innovate their digital experience and customer engagement strategies.

Matt is a digital strategist with an enterprise technology focus. He brings a wealth of experience across digital agency and corporate environments and has contributed to many enterprise digital transformation initiatives.

His experience in the Pharma industry includes projects for Johnson & Johnson, Sanofi, Pfizer, and Sharp Healthcare. He possesses a unique appreciation for the user experience design process along with keen understanding of digital technologies, user experience, and data platforms.

Matt participates directly in client’s experience design workshops and strategy sessions, sharing his insights and experiences at various industry events and conferences.

Joan Arata

Joan Arata

Senior Vice President, Everyday Health Professional

Read more

Joan is a Registered Nurse, who, after practicing clinically in adult medical intensive care, moved into medical communications. The majority of her career has been focused on medical education and communications to health care practitioners (HCPs).

Joan was Managing Director of a medical education communications company that she acquired and, ultimately sold to Publicis Health. Once she completed this transaction, Joan went to Medscape CME, where she was recruited to build the newly created Medscape CME sales organization to meet the firewall requirements of separating promotion from CME.

Joan joined Everyday Health in June, 2015. Joan is SVP of the Everyday Health Professional sales organization where she leads a team that spans from Sales Strategy to Field Sales, to Post-Sales Execution. This team works in partnership with Pharma and Biopharma and their agencies to drive strategies to increase conversations with healthcare professionals that, ultimately lead to improved patient care.

Joan is a leader in recognizing trends in HCP communications and education, and as such, frequently moderates panels and discussions at major industry events focusing on these topics.

The Triple Aim Speakers

Nisith Kumar

Nisith Kumar

Director- Global Patient Affairs, Pfizer

Read more

Mr. Kumar is a Director of Global Patient Affairs (GPA) which is accountable for driving end to end patient centricity across Pfizer. In this role, Mr. Kumar co- leads an initiative to drive patient centricity within Pfizer’s Global Product Development team. External leadership roles include co-leading a TransCelerate initiative to increase the awareness of clinical trials in the public domain. Mr. Kumar also has Pfizer operational responsibilities that include among others, goal alignment, budget management, GPA’s Goals Dashboard updates, and Op Planning and running specific projects such as the Bioethics Advisory Panel, Multi-Company initiatives, and leading the OWNers team, a change management initiative within Pfizer Medical. Prior to this role, Mr. Kumar was a Director of Project Management for the office of the Chief Medical Officer.

In this role, he served as the point of accountability for assuring all projects within CMO’s office were prioritized, had clear tangible deliverables and adhered to a project plan. His responsibilities were to assure there was adequate follow up and guidance with the key strategic initiatives; so, that they were tracked and delivered on time. Mr. Kumar has a broad background in the operational delivery of clinical trials. Moreover, his unique skill set of being able to collaborate across functions, companies and cultures, strong leadership experience from running cross-functional study teams and his knowledge of project management disciplines served him well to monitor and drive the vast array of initiatives. Mr. Kumar started his career at a small CRO (Coromed, now part of Omnicare) as a CRA in 1995. After a brief role as a PM, he joined Pfizer in 1998 as a Study Manager with the World Wide Aricept Team and switched to another co-promoted product, Rebif in 2003. In his most recent position as a Clinical Project Manager (operational lead within DevOps), he led several study teams for Lipitor, Lyrica and Apixaban.

Ramana Sonty, MBBS, PhD.

Ramana Sonty, MBBS, PhD.

Director, Global Medical Organization, Johnson & Johnson

Read more

More information coming soon...

Ann Kwong

Ann Kwong

CEO & Founder, TREK Therapeutics

Read more

Ann Kwong is an internationally recognized industry leader in antiviral drug discovery and development and the co-founder and CEO of Trek Therapeutics. Trek is committed to developing affordable and accessible drugs to treat infectious diseases globally. Trek is conducting Ph2 clinical trials to develop a potentially best-in-class, ultra-short (4-6 week) HCV regimen to cure patients infected with HCV genotype 1 (GT1). Prior to Trek, Ann founded the infectious disease group at Vertex Pharmaceuticals and played a leading role in the discovery, development, and commercialization of telaprevir (INCIVEK™), a HCV protease inhibitor with >$1B in revenue in its first year.

Roslyn Schnider

Roslyn Schnider

Global Patient Affairs Lead, Pfizer Medical

Read more

Roz is the Global Patient Affairs (GPA) Lead within Pfizer’s Chief Medical Office. Roz’s team drives more systematic, end to end patient centricity at Pfizer. She received her BS from the Sophie Davis School of Biomedical Education of the City College of New York, MD from Mount Sinai School of Medicine, and MSc in Pharmaceutical Medicine from Hibernia College. A retired Clinical Professor of Medicine of Albert Einstein College of Medicine, an Internist, Pulmonologist, Intensivist, she practiced for twenty years. She published in the areas of pulmonary complications of HIV infection, venous thromboembolic disease, medical ethics and medical education.

Jamie Burks

Jamie Burks

Patient Experience Lead, Patient Value Unit, UCB

Read more

More information coming soon...

Liza Maricle

Liza Maricle

RN, Right Start Nurse Educator

Read more

More information coming soon...

Susan Garfield

Susan Garfield

Principle, EY

Read more

Dr. Garfield heads up the Commercial Strategy and Market Access function within the Life Science Advisory practice. She helps life science companies optimize the value propositions, maximize launch opportunities, transform commercial models, and drive customer centricity. Previously, she was Executive Vice President, Healthcare Consulting Services at GfK. She led their US Market Access practice which spanned pharma, biotech, medical device, diagnostic and specialty pharma clients.

Prior to that Dr. Garfield ran global market access, pricing, and health economics at QIAGEN, focusing oncology and precision medicine (previously Digene). After graduate school, Dr. Garfield held various consulting roles at Boston Healthcare Associates, leading their Commercial and Health Economics practice after a 6 year tenure at the firm. Dr. Garfield has published numerous articles, chapters and a book on healthcare payment issues, also having multiple speaking engagements and poster sessions at industry and academic conferences.

Dr. Garfield holds a Doctorate of Public Health from Boston University, a Master of Science Health Policy and Management from Harvard University, a Master of Science in Population and Development from London School of Economics, and a Bachelor of Arts from the University of Pennsylvania.

Maryellen Royle

Maryellen Royle

Global CEO, Tonic Life Communications

Read more

Maryellen Royle is a respected public relations strategist who has partnered over the past 20+ years with leading global organizations in pharma, biopharma, device and diagnostics, and consumer products. She is a natural leader who attracts top talent to Tonic. Maryellen forms lasting relationships with her clients and colleagues, bringing them the benefit of her experience and innovative ideas to deliver success. Maryellen is honored to have been recognized for her industry contributions, being named among the “Top Women in PR” by PR News and featured in PharmaVOICE 100. She resides in Wayne, PA with her husband and three daughters.

Commercial Model Innovation Speakers

Peter Sandor

Peter Sandor

TA Head Oncology Marketing Strategy, Astellas

Read more

Peter Sandor Vice President, Head of Oncology Therapeutic Area Marketing Strategy. In this role, Peter provides commercial leadership for project’s within the oncology therapeutic area and plays an integral role in the expansion of Astellas’s presence in oncology

Peter has 20 years of progressive marketing experience. He was recently the Vice President, Global Marketing Oncology at Amgen responsible for the successful realization of the commercial potential for Amgen’s oncology assets. Prior to Amgen, he has held different positions at Bayer Healthcare, including Head of Strategy and Portfolio Management Specialty Medicine, Commercial Development and Life Cycle Management Global Oncology. He also worked for Berlex Laboratories as the lead of the global launch team for a key oncology compound, and held multiple marketing roles with Schering AG in Germany and Hungary.

Peter started his career in bench research as a scientific advisor of the Hungarian Academy. He received his MDS Marketing and MBA from Middlesex University, London and Faculty of Business and Economy, University of Pécs, Hungary, and his MD from University of Pécs, Hungary.

Chris Sellin

Chris Sellin

Head of Operational Excellence & Analytics, Shire

Read more

Christopher Sellin is currently the Head of Operational Excellence & Analytics at Shire. Prior to this role, he cultivated broad pharmaceutical knowledge via Sales Management, Marketing, Analytics and Operations roles at Baxalta, Novartis and Eli Lilly. Chris is a certified Lean Six Sigma Black Belt who has worked on developing effective Sales and Marketing processes and frameworks within US and Global organizations. He graduated from Temple University in Philadelphia, PA with a B.A. in Journalism / Advertising.

Heather Dean

Heather Dean

National Head, Specialty Sales & Accounts, Takeda

Read more

Heather Dean is the National Head of Specialty Sales and Accounts at Takeda Pharmaceuticals USA, Inc. She is responsible for leading the Biologic Clinical Sales Specialist team as well as the Key Account Manager team charged with managing large, complex IBD accounts.

Heather’s pharmaceutical experience is focused in the areas of marketing and sales leadership. Her commercial brand leadership experience at Eli Lilly and Company, TAP Pharmaceuticals and Takeda includes the therapeutic categories of diabetes, CNS, metabolic disorders and GI. In addition to specialty sales leadership, Heather has also managed large sales forces in the general medicine arena.

William King

William King

Founder and Executive Chairman, Zephyr Health

Read more

William King is the founder and Executive Chairman of Zephyr Health; the Insights-as-a-Service leader harnessing the power of global health data to help Life Sciences companies engage the right physicians, accounts and institutions. He is passionate about creating innovative solutions to advance efficiency, strategy and tactical problem solving for Life Sciences companies

Under his leadership, Zephyr Health has grown to serve leading pharmaceutical, biotech, medical device and diagnostic companies globally. Zephyr has also received numerous industry accolades, including being named one of Gartner’s “Cool Vendors in Life Science,” PM360’s “Most Innovative Start-ups in 2015,” and Insights Success’ “20 Most Valuable Enterprise Big Data Companies.”

At multinational Johnson & Johnson, William held a range of global leadership positions in sales, marketing, training and strategy. He was also a member of the International Development Program for global leadership and people development.

William has participated in some of the industry’s most prestigious conferences including Big Data in BioMedicine, BIO International Convention and Digital Healthcare Innovation Summit. He speaks regularly on:

  • What you Need to Know About Creating a Big Data Strategy
  • Unfashionably Late to the Big Data Party: How Biopharma Can Catch Up
  • The Big Data Prescription for Pharma Marketing

William holds a Bachelor of Science in Business Administration from the University of Denver and serves on the American Heart Association Research Roundtable Executive Board. He currently resides in the Bay Area with his wife and two children.

Kim Murphy

Kim Murphy

VP, Global Vaccines Commercialization Leader, Influenza, GSK

Read more

Kim Murphy is Vice President and Global Vaccines Commercialization Leader for GSK’s Influenza Franchise. In this role, Kim leads GSK’s global influenza vaccines business and is accountable for both U.S. performance and the cross-functional Vaccines Commercialization Team, including global flu pandemic preparedness across vaccines and anti-virals.

A pharmaceutical industry and Vaccines veteran for more than 20 years, Kim recently led the North American integration of all commercial assets of Novartis Vaccines following GSK’s 2015 acquisition and spearheaded efforts to improve GSK Vaccines’ delivery of customer value, by running a 40-person US marketing and access team for the world’s largest vaccines manufacturer.

Christine Richards

Christine Richards

Director Quality Academy, Sanofi Pasteur

Read more

Christine (Chrissy) Richards currently serves as Director for the Sanofi Pasteur Quality Academy. As a formally trained Master's Degreed Chemist with a passion for people, Chrissy found success in the Sanofi Pasteur Quality Organization and is currently providing leadership and expertise in the development and deployment of Good Manufacturing and Distribution Practices training programs. Chrissy is a leader in the Sanofi Pasteur organizational transformation movement focused on reinventing the employee and leader relationship by engaging and empowering all individuals to achieve collective performance. This work has been recognized on a global scale by achieving the FICCI Quality Systems Excellence Award (2017), Outstanding Human Performance Improvement Award (2017), Organizational Culture Excellence Award (2016), Gold Quill Award (2016), and Employee Engagement Award (2016).

Robert P Draper

Robert P Draper

Sr Director, Lilly BioMedicines Forecasting, Eli Lilly and Company

Read more

Bob has 25 years of experience in forecasting and marketing analytics and for the last 20 years has been focused on the pharmaceutical industry. Bob began his career in finance, moved to marketing analytics consulting working across multiple business sectors in Europe. He joined Eli Lilly in Indianapolis where he has led the Global Forecasting team since 2000, and most recently leads the Biomedicines and Emerging Markets forecasting teams. His responsibilities include Strategic Planning, New Product forecasting, inline forecasting, business development and forecasting capabilities. Bob has an MA in Mathematics from the University of Oxford. He is a member of the advisory board for Kelley School of Business Analytics.

Roger Sawhney

Roger Sawhney

SVP Industry Strategy, Outcome Health

Read more

Senior Vice President of Life Sciences Strategy and Business Development

As senior vice president of life sciences strategy and business development, Roger leads Outcome Health's efforts to develop relationships and partnerships with the world’s leading life sciences companies. With 20 years of experience in the biopharmaceutical industry, Roger focuses on developing, coordinating and implementing strategies to help Outcome Health’s brand partners meet their business goals.

Roger was previously a partner in Bain and Company’s global healthcare and private equity practices, where he enabled healthcare companies to drive strategic position and competitive advantage. He also worked at Novartis as senior vice president and global head of corporate strategy, leading the company’s long range planning, business growth and eHealth efforts, as well as emerging market strategy. He serves on the Board of Directors for the New York Institute of Technology (NYIT).

John Gerow

John Gerow

Global Head, Customer Service Model, Ashfield

Read more

John is currently working with Ashfield as the Strategy Partner on the service team model. Prior to this John worked for 6 years in global commercial excellence with AstraZeneca and has extensive experience with New Commercial Models (NCM). John has pioneered many new capabilities, successfully launching pharma’s first service team model in 2008. He joined the Global Marketing and Sales group in 2010 as the Vice-President of Sales and New Channels, where he led the launch of NCM across 33 markets.

Previous experiences include: Sales, Sales management, Government Affairs Manager, Business Unit Director, Executive Director of Innovation as well as starting his own Marketing Agency. John holds an MBA from Ivey Business School, University of Western Ontario, Canada.

Roundtable Speakers

Laurie Cooke

Laurie Cooke

CEO, Healthcare Businesswomen's Association

Laurie Cooke is the CEO of Healthcare Businesswomen’s Association, a nonprofit with 50,000 members and 121 companies, dedicated to furthering the advancement and impact of women in healthcare. Laurie is a dedicated advocate for gender parity, speaker, thought leader, PharmaVOICE 100 most inspiring people in life sciences, and ASAE Mentor of the Year. Laurie served on PMI’s executive management team; on international teams in process improvement, team effectiveness, project management in pharma; and hospital pharmacist. Laurie graduated with a degree in Microbiology from U of MD, advanced scientific degree in Pharmacy from U of WA, masters in Software Engineering Management from U of Luton, England, licensed Pharmacist, and Certified Association Executive.

Mark Bard

Mark Bard

Founder, Digital Health Coalition

Read more

Mark Bard is a new media, marketing, and technology entrepreneur. In addition to personal ventures, he also invests in early stage technology and digital health startups taking an active advisory role with founders. With deep expertise in the digital health space, Mark’s focus and passion includes mobile, analytics, and customer service in a digital world. He previously sold Manhattan Research, a company he co-founded, to Providence Equity Partners. Mark co-founded the Digital Health Coalition, a non-profit think tank based in NYC, in 2011 and is actively involved in the continued growth of the organization.

Bob Kelly

Bob Kelly

Chairman, Sales Management Association

Robert J. (Bob) Kelly is chairman of The Sales Management Association (www.salesmanagement.org), a global, cross-industry association for sales management and sales operations. The Sales Management Association serves members in 50+ countries with research, conferences, and peer networking, and hosts the annual Sales Force Productivity Conference (www.salesmanagementconference.com).

Bob was previously vice president of sales operations and strategy at Genuine Parts Company, and worked in marketing strategy for MCI WorldCom. He teaches a sales management course to MBA students as an adjunct professor at Emory University’s Goizueta Business School’s in Atlanta.

Jill Donahue

Jill Donahue

Co-Founder, The Aurora Project

Jill Donahue believes there is an important role for pharma professionals in the pit crew surrounding the patient. As a consummate student, author and speaker on behavior change in healthcare, she helps pharma professionals learn how to become trusted, valued, influential partners to healthcare providers. She empowers them with a new way of selling and a system of what to say and do.

She is the author of EngageRx: The 3 Keys to Patient-focused Growth, founder of Excellerate and co-founder of The Aurora Project, a global group of pharma professionals united in their desire to illuminate the path to patient centricity.

Melva Covington

Melva Covington

Senior Director, Health Outcomes and Value Assessment, Pacira Pharmaceuticals

Dr. Covington joined Pacira Pharmaceuticals as Senior Director, Health Outcomes and Value Assessment, in February 2017. She has held leadership roles in R&D, Health Outcomes, Medical Affairs and Medical Operations at Sanofi (2010- 2017), Eli Lilly (2004-2010) and Roche Labs (2000-2004).

Her leadership and expertise are in public health, market access, strategic thinking, health outcomes and operations; and cover all levels of drug development and across therapeutic areas. Her work also focuses on reducing disparities in health outcomes and evaluating cultural competency.

She has degrees in Politics, Economics, Public Health, Education and Business. Melva has authored numerous publications and is an impassioned public speaker.

Felicia S. Johnson

Felicia S. Johnson

Patient Advocate

Read more

Felicia Johnson is an intentional woman with a purpose to fulfill. She was diagnosed with Stage IV breast cancer in 2003 and in 2010 with Triple Negative Cancer. She is a Speaker, Patient and Community Advocate. Her journey includes a family history of eleven women diagnosed with breast cancer over three generations. She knows the importance of patient participation during illness and survivorship. Felicia believes her strongest asset is her faith and passion to help others affected by cancer. Her goal is to empower through education. She volunteers at various cancer organizations and is an inspirational writer and blogger.

Medical Affairs Speakers

Kate Knobil

Kate Knobil

Chief Medical Officer, Pharmaceuticals, GSK

Read more

Kate is the Chief Medical Officer for Pharmaceuticals at GSK. The mission of her group (Pharma Medical and Patient Safety) is to understand the current and future needs of patients, clinicians and healthcare systems to generate and communicate evidence that informs on the benefits, risks and overall value of GSK medicines.

Kirk Shepard

Kirk Shepard

President, Medical Affairs Professional Society & Senior Vice President, Head of Global Medical Affairs Oncology, Eisai Pharma

Read more

Dr. Kirk Shepard is the 2016-2017 President of the Medical Affairs Professional Society (MAPS) and has more than 25 years of experience in the pharmaceutical industry. He is a board-certified medical oncologist and hematologist physician. He is currently Senior Vice President, Head of Global Medical Affairs Oncology at Eisai Pharmaceutical Company.

Dr. Shepard’s experience in multiple therapeutic areas includes operational and strategic product development from Phases I through IV and the diverse disciplines of medical affairs and product commercialization, such as leading compliance and SOP/policy efforts, health economics & outcomes research & patient access, data generation, field-based medical teams (MSLs), PV/safety, medical communication & publications, patient advocacy, and public relations. In 2015, he was selected as one of the 100 Most Inspiring People in the Pharmaceutical Industry (PharmaVOICE).  Before his pharmaceutical career, Dr. Shepard served as a staff physician in the Department of Hematology and Medical Oncology at the Cleveland Clinic Foundation, where he supervised numerous studies in oncology and symptom control. He has more than 50 medical publications in journals and books.

Dr. Shepard earned his bachelor’s degree from Cornell University in Ithaca, NY, and his medical degree from the University of Cincinnati Medical School in Cincinnati, OH. He completed both his internship and residency in internal medicine at Case Western Reserve University in Cleveland, OH, and fellowships in hematology and oncology at the University of Chicago Hospitals and Clinics in Chicago, IL.

Alan Wright

Alan Wright

Chief Medical Officer, Roche Diagnostics

Read more

As the Chief Medical Officer for Roche Diagnostics Corporation, Alan serves as our clinical spokesperson and lead counsel on everything from the policy to the practice of diagnostic medicine. With his extensive history in the managed care, pharmaceutical and biotechnology industries, Alan is well-versed in the changing landscape of healthcare including emerging trends and technologies, regulatory and legislative hurdles, payer challenges and the growing relevance of diagnostics with the advent of outcome-based reimbursement.

Alan brings with him medical and scientific leadership experience from his work from a variet. He earned his medical degree from University of Pennsylvania School of Medicine and a masters of public health degree from Johns Hopkins School of Public Health and Hygiene.

Shontelle Dodson

Shontelle Dodson

Vice President, Medical Excellence/Medical Affairs Global, Astellas

Read more

Dr. Shontelle Dodson is Vice President, Medical Excellence within the Global Medical Affairs organization at Astellas Pharma and has extensive clinical and research experience in the healthcare and pharmaceutical industries. After several years of service in direct patient care at the Department of Veterans Affairs, Shontelle spent 11 years at Pfizer, Inc. in various Medical Affairs leadership roles across the Urology and Respiratory franchises. Following her work with Pfizer, she served as Vice President, Medical Affairs at GTx, Inc. In this capacity Shontelle led the Phase 3 clinical development of a selective androgen receptor modulator for the prevention and treatment of muscle wasting in patients with cancer including incorporating key economic and health outcomes assessments to support product utilization and valuation. Under her leadership at Astellas, the Medical Affairs group has pioneered multiple, innovative real world data projects including two national registries in prostate cancer and overactive bladder, as well as partnered research with leading managed care and academic organizations.

Shontelle has received multiple awards for leadership and innovation during her career, including the National Healthcare Business Women’s Association Rising Star and Astellas Vision Award. Dr. Dodson holds a Doctor of Pharmacy degree from Mercer University School of Pharmacy and completed a postdoctoral residency at the Department of Veterans Affairs Medical Center in Nashville, Tennessee.

Rosh Dias

Rosh Dias

Vice President, Global Scientific Affairs, Amgen

Read more

Rosh Dias, M.D., MRCP, is a UK trained physician with 17 year’s industry experience in a set of functionally and geographically diverse Medical Affairs roles in both large pharma and biotech.

Currently serving as Vice President of Global Scientific Affairs at Amgen, he leads global and regional organizations responsible for Scientific Communications, Medical Writing, and Medical Science Liaisons across all Amgen therapeutic areas.

Rosh has had prior roles at Onyx Pharmaceuticals, and Novartis Oncology, where he has led Global Medical Affairs programs for key compounds, Country Medical Organizations, and Field Medical Organizations.

Paul Rowe

Paul Rowe

Vice President, Global Medical Affairs Head, Airway/Respiratory, Sanofi Genzyme

Read more

Dr. Rowe has well over a decade of research experience spanning from pre-clinical to late phase drug development programs, primarily in respiratory (and cardiovascular) medicine. He has been directly responsible for medical strategy and lifecycle management of several Chronic Obstructive Pulmonary Disease (COPD), asthma, and cardiovascular medicines. Dr. Rowe has been successfully involved in achieving New Drug Application (NDA) approvals for first in therapeutic class respiratory products and also has led various clinical development global projects from phase II through phase IV clinical trials. He has authored and co-authored several publications in respiratory medicine (COPD-focused, and is a frequent lecturer and speaker at professional society meetings, and educational forums. Dr. Rowe holds degrees from Harvard University and the University of Rochester School of Medicine, and certifications from the London School of Economics and Villanova University.

Dr. Rowe is an active member of several national and international societies and he recently served as Vice Chair of the Drug, Device, Discovery, and Development Committee of the American Thoracic Society (ATS). He has a primary interest in promoting international medical research collaboration and innovation across government, academia, and industry.

In his current role, Dr. Rowe is responsible for building and leading a Global Medical Affairs team and strategy within the respiratory space for several novel compounds in mid and late stage development, in various therapeutic indications.

Stanislav Glezer

Stanislav Glezer

former Vice President, Medical Affairs, Novo Nordisk

Read more

Stan Glezer, MD, MBA is an industry physician, passionate in optimizing value of phamecutical innovation for the patients, through partnering with the healthcare system.

Until recently, he served as Vice President of US Medical Affairs at Novo Nordisk Inc. Prior to joining Novo Nordisk, Stan has worked at Sanofi where, most recently, he led the development, regulatory submission, and launch preparation of Toujeo.

He brings with him extensive knowledge of medical affairs at an affiliate and Global level, as well as of the commercial areas of pharmacueitcal business and has held leadership roles in post-marketing research, epidemiology, medical information, medical communications, HEOR, interfacing with regulatory agencies, market access, and overall lifecycle management

Although his activities in the past few years were predominatly focused on diabetes, Stan has worked in multiple theraputic areas, including osteoporosis, oncology, immuno-inflammation, obesity, thrombosis, bleeding disorder and rare diseases. HE has a strong track record of leading the teams in establishing collaborations with healthcare providers, key opinion leaders, payers, and professional associations.

Stan received his medical training in Russia and has worked in Canada and in France for the past 20 years. He has an MBA from California Coast University and completed his graduate work in Clinical Research at McGill University.

Dana Evans

Dana Evans

Director for Patient Access, Collaboration and Exchange, Genentech

Read more

Dana Evans is the Director for Patient Access, Collaboration and Exchange with Genentech Medical Affairs. Dr. Evans manages a team of clinicians that provides scientific, clinical and managed care professional support to account teams who are responsible for payers, hospitals, government programs, group purchasing organizations and product distribution companies.

Dr. Evans obtained his medical degree from the University of Texas Medical School at Houston and completed his residency in Family Medicine at Southwest Memorial Hospital in Houston. He practiced family medicine in Texas, including obstetrics and surgery, for seven years. In 1992, he left clinical practice to begin a career in administrative medicine. His resume includes positions as medical director, chief medical officer and executive officer for regional and national health plans. He has also been a managed care consultant for health plans and physician organizations. He moved to the pharmaceutical industry as a medical director for managed care with GlaxoSmithKline in 2001. Dr. Evans joined Genentech in 2008 as a medical director for Value Based Healthcare.

Lav (Bobby) Parvathenani

Lav (Bobby) Parvathenani

Specialty Medical Information Lead, US Medical, Bristol-Myers Squibb

Read more

More information coming soon...

Diane McDowell

Diane McDowell

Head, Global Scientific Affairs Oncology, GSK

Read more

Diane McDowell recently returned to GlaxoSmithKline with over ten years of industry experience. Diane is a fellowship trained, board certified, surgical oncologist. She is also an award winning, pharmaceutical executive with oncology and immuno-oncology experience in both clinical development and medical affairs. Diane’s work has spanned both US and international markets for Bristol-Myers Squibb, GlaxoSmithKline, and Merck. Diane’s clinical development experience includes indication file lead and regulatory interaction. Her Medical Affairs experience includes building and leading large teams, medical matrix team creation and management, Phase IV study leadership and Investigator Sponsored Study Program leadership.

Prior to joining industry Diane was in clinical practice as a general and breast cancer surgeon. Diane completed her fellowship training at Fox Chase Cancer Center, and her surgery residency at Tulane University and Charity Hospital in New Orleans. Her industry career started at BMS in 2007 where she spent over 5 years in various roles. Starting as US medical lead for Ixempra in breast cancer, and expanding into other roles including a regional role in the EU launch of Yervoy in melanoma, Medical Affairs lead for the Imclone/BMS lung cancer initiatives involving Necitumumab, and medical monitor for both lung and melanoma ipilimumab trials. In her capacity on the Yervoy team, she was involved in the Yervoy safety management training and education of her peers as well as external investigators.

In 2013, she joined GSK as an Executive Director, Medical Affairs Lead for Tafinlar/Mekinist where she created and implemented a plan for successful launch of Tafinlar/Mekinist into the U.S. Market. She led cross functional collaboration to develop and execute the USMA plan for combination therapy, led Phase IV studies, and served as medical point person for external communication and advocacy groups. In 2015, Diane was asked to lead US Oncology Global Medical Affairs at Merck. While there, Diane built a team of over forty-five people to support the growing Keytruda franchise.

Roslyn Schneider

Roslyn Schneider

Global Patient Affairs Lead, Pfizer

Read more

Roz is the Global Patient Affairs (GPA) Lead within Pfizer’s Chief Medical Office. Roz’s team drives more systematic, end to end patient centricity at Pfizer. She received her BS from the Sophie Davis School of Biomedical Education of the City College of New York, MD from Mount Sinai School of Medicine, and MSc in Pharmaceutical Medicine from Hibernia College. A retired Clinical Professor of Medicine of Albert Einstein College of Medicine, an Internist, Pulmonologist, Intensivist, she practiced for twenty years. She published in the areas of pulmonary complications of HIV infection, venous thromboembolic disease, medical ethics and medical education.

Karen Lowney

Karen Lowney

Executive Director, Global Compliance, Privacy & Transparency, Astellas

Read more

Karen Lowney is the Executive Director, Global Compliance, Privacy & Transparency at Astellas Pharma, where she is responsible for providing compliance support to Global functions, including Development, Medical Affairs and Marketing Strategy. She is responsible for Transparency Reporting as well as managing systems and processes that govern various interactions with healthcare professionals and healthcare organizations. She also serves as the Americas Privacy Officer.

Prior to Astellas, Karen was the Senior Director of Global Compliance at Cephalon, where she managed compliance across business units including the development, implementation and oversight of policies, procedures and processes, employee training, aggregate spend tracking and government reporting, monitoring, incident management and investigations, and providing day-to-day advice to business partners.

Karen previously served as the Director of International Compliance at Schering-Plough where she was responsible for implementation of compliance initiatives within the Global Pharmaceutical Business, coordination of their compliance officer network, and ensuring policies, procedures and processes adhered to corporate guidelines as well as local laws, codes and regulations.

She holds a B.S.B.A in Accounting from the University of Missouri and is a Certified Internal Auditor.

Leonard Friedland

Leonard Friedland

Vice President, Director Scientific Affairs and Public Policy, Vaccines North America, GSK

Read more

Dr. Leonard Friedland is Vice President, Director Scientific Affairs and Public Health, Vaccines North America at GSK. He is also a licensed pediatrician in the state of Pennsylvania. Dr. Friedland has held many positions in clinical research and development with GSK since 2003, specializing in infectious disease vaccination.

Prior to his work at GSK, Dr. Friedland was Division Chief, Pediatric Emergency Medicine at Temple University School of Medicine. Dr. Friedland studied medicine at Mount Sinai School of Medicine in New York and conducted his residency in pediatrics at the Children's Hospital of Philadelphia and his fellowship in pediatric emergency medicine at St. Christopher's Hospital for Children, also in Philadelphia.

He is currently a fellow and active member of the American Academy of Pediatrics and has published over 39 peer reviewed articles during his career.

Janet Baldwin

Janet Baldwin

Vice President, Real World and Late Phase, INC Research

Read more

Janet Baldwin has over 30 years of drug development experience, working for both large pharma and clinical research organizations. She has a B.S. in Biochemistry and began her career as an analytical chemist developing and validating methods for detection of new drug entities in the pre-clinical and clinical pharmacology settings. Her responsibilities included the development of an analytical lab in support of the bioanalytical group at Hoffmann – La Roche. Janet then became a Clinical Research Associate where she developed protocols, CRFs and recruited and managed sites for multiple phase II and III studies. Her career progressed to clinical study/trial management and then department management. Janet has built and lead departments across a number of functional areas including, project management, analytics, clinical research, feasibility, site identification and patient recruitment. For the past 10 years Janet has focused on Late Phase Research. While at Quintiles, Janet was the Americas Head of Late Phase Project Management and Analytics, designing and overseeing Observational (both prospective and retrospective), phase IV interventional, large Outcomes Studies and Expanded Access Programs (EAPs). Her experience also includes serving as a principal investigator for an observational study where patients were recruited using pharmacy data. As Global Head of Clinical Operations, Observational Research at PAREXEL, she created a clinical team for the purpose of providing site management support for observational studies. Janet is currently Vice President for Real World and Late Phase at INC Research.

Elizabeth Engelhardt

Elizabeth Engelhardt

Head of Specialty Strategy & Clinical Management, Aetna

Read more

Elizabeth Engelhardt is the Head of Specialty Strategy and Clinical Management Programs for Aetna Pharmacy Management. In this role Ms. Engelhardt is accountable for the development, design and execution of clinically sound, cost conscious Specialty medical and pharmacy pharmaceutical management for Aetna Commercial members. Prior to her current role, Ms. Engelhardt was the Director of Trade Relations for Aetna Pharmacy Management, accountable for setting strategic plans for Aetna’s relationships with Pharmaceutical Manufacturers, managing a portfolio of rebate contracts and creating and maintaining valuable partnerships within the manufacturer community. She joined Aetna in 2011.

In addition to her Aetna experience, Ms. Engelhardt held management positions within the health care industry with various companies including Novartis Oncology, BioScrip, Inc, Teva Pharmaceuticals and Merck. Her clinical experience includes Pediatric Nursing, Pediatric Oncology Nursing, Adult Oncology Nursing and Nurse Management.

She holds a Bachelor of Science degree in Nursing from Molloy College, Rockville Center, NY.

Soumi Saha

Soumi Saha

Assistant Director of Pharmacy & Regulatory Affairs, Academy of Managed Care Pharmacy (AMCP)

Read more

Soumi Saha serves as the Assistant Director of Pharmacy & Regulatory Affairs at the Academy of Managed Care Pharmacy (AMCP). Soumi joined AMCP in July 2015 and is responsible for advancing the interests of its members by advocating the Academy’s regulatory positions at the federal and state level. Prior to joining AMCP, Soumi worked for Kaiser Permanente where she held various positions and most recently served as the Director of National Pharmacy Controls. Soumi has a Doctor of Pharmacy (PharmD) from the University of Maryland School of Pharmacy and a Juris Doctor (JD) with a concentration in Health Law from the University of Maryland School of Law.

Patrick Reilly

Patrick Reilly

CEO, phactMI

Read more

Patrick Reilly is currently CEO for phactMITM, a collaboration of pharmaceutical company Medical Information (MI) departments that are dedicated to supporting healthcare professionals in their commitment to provide quality patient care. Patrick is also principal at Reilly Consulting, LLC, focusing on pharmaceutical medical affairs management.

Patrick has spent the past 30 years within the Pharmaceutical Industry, primarily at Bristol Myers Squibb within the R&D/Medical Affairs organization. During his tenure at BMS, Patrick worked in a variety of leadership roles with a focus on building and enhancing organizational capabilities like clinical trial monitoring, global field medical, and most recently globalizing medical information.

As Vice President of Medical Information at BMS he led the globalization of the organization, leveraging technology and establishing innovative multi-channels to enhance the exchange of medical and scientific information for HCPs. Patrick was also actively involved in the people strategy at BMS, talent acquisition and development, where he was the executive sponsor of the PharmD Fellowship/Residency program.

Patrick has a bachelor’s degree in Biology, a bachelor’s degree in Medical Science (as a Physician Assistant) and a Master’s Degree in Business administration. He is an active member of the Drug Information Association (DIA) and the American Society of Association Executives (ASAE) and is a frequent presenter at Life Sciences conferences.

Lynn Vos

Lynn Vos

CEO, ghg | greyhealth group

Read more

More information coming soon...

Joe Kohles

Joe Kohles

Chief Medical Officer, Envision Pharma Group

Read more

More information coming soon...

Honorio Silva

Honorio Silva

President, IFAPP (International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine)

Read more

Dr. Silva’s professional career has focused on fostering clinical research and medical education with focus on emerging countries, in addition to serving the pharmaceutical industry, academia and various professional associations. After 30-years of service with Pfizer Inc, Dr. Silva retired as Vice President, Science and Medical Professional Development, within the External Medical Affairs group. He also served as Vice President, Medical and Regulatory Affairs, Japan, Asia, Africa & Latin America and Director/Team Leader Medical Operations, Latin America & Canada. He was also Assistant Professor of Clinical Pharmacology at the Universidad Central de Venezuela Medical School.

All Speakers

Cheryl MacDiarmid

Cheryl MacDiarmid

SVP and Business Unit Head US, Primary Care, GSK

Read more

Cheryl MacDiarmid is a member of the senior executive team in the US for GSK, a leading, multinational global pharmaceutical company. She is directly responsible for the US primary care sales division; strategy, planning and operations; and marketing, leading more than 2500 employees. A dynamic and strategic general manager, Cheryl brings 20 years of deep experience in building businesses in the US and Canada across sales, marketing and managed markets in both pharmaceuticals and vaccines.

She has a gift for creating and leading extraordinarily powerful teams. She seeks out and thrives on challenge, leading her teams to set an ambition, make choices and execute bold, game-changing moves that pivot and change a business trajectory. Notable recent accomplishments include catalyzing a significant turnaround within the US sales organization while solidifying a path to sustained growth and launching a new type 2 diabetes medicine in the US, exceeding external benchmarks and market expectations.

She is a values-driven leader with significant experience managing commercial risk, compliance and alliance governance. As a pharmacist, Cheryl navigates complex scientific and clinical data with ease and has a passion for respiratory disease and diabetes. She brings a global mindset to her work, having served as a chief of staff associate to the GSK President, International Region.

A native of Canada, Cheryl graduated from the University of Toronto with a degree in Pharmacy and subsequently received an MBA from the Schulich School of Business. She lives in Philadelphia. Her personal passions include running, skiing, and visits north to Canada.

Kabir Nath

Kabir Nath

President & CEO, Otsuka North America

Read more

Kabir is a senior commercial leader with more than 25 years of broad international biopharma and devices experience who has shaped strategy and delivered results in complex, challenging business environments at country, regional and global levels. He has lived and worked in the U.K., France, Spain, India, Singapore, China and the US.

Kabir joined Otsuka to head the North American pharmaceutical business in March 2016, with direct responsibility for Otsuka America Pharmaceuticals, Inc., Avanir and Otsuka Canada. Before joining Otsuka, Kabir spent 13 years in leadership roles at Bristol Myers Squibb. Most recently he was Senior Vice President, Virology, Transplant & Optimized Brands, responsible for the commercialization of a significant portfolio – including drugs for HIV, hepatitis B and hepatitis C and immunosuppression - in the USA.

Previously he was Senior Vice President, Global Commercialization - Virology & Neuroscience, leading global strategy for these two disease areas. In addition he served as interim head of Emerging Markets for much of 2012.

Kabir joined BMS in Singapore in 2003 as vice president for South East Asia/Taiwan/HK and moved to Shanghai in 2005 as president of BMS China. In 2008, Kabir was appointed president, Asia Pacific Medicines, with responsibility for all commercial operations in 13 countries. Prior to joining BMS, Kabir spent 11 years at Smith & Nephew, the medical technology company, in senior operational and strategic roles in the U.K., Europe and Asia. Kabir holds an MA from King’s College, University of Cambridge, and an MBA with Distinction from INSEAD.

Andy Schmeltz

Andy Schmeltz

Senior Vice President of Patient & Health Impact, Pfizer Innovative Health

Read more

More information coming soon...

Julie Gerberding

Julie Gerberding

Executive VP & Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health, Merck

Read more

Dr. Julie Gerberding is Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy, and Population Health at Merck & Co., Inc., where she also has responsibility for the “Merck for Mothers” global program to prevent maternal mortality and the Merck Foundation. She joined Merck in January 2010 as president of Merck Vaccines and led efforts to make the company’s vaccines more available and affordable to people in resource-limited countries around the world.

She left her tenured faculty position at the University of California, San Francisco in 1998 to lead the U.S. Centers for Disease Control and Prevention (CDC) Division of Healthcare Quality Promotion and then served as the CDC Director from 2002 to 2009. As director, she led the CDC through more than 40 emergency responses to public health crises, including anthrax bioterrorism, SARS, and natural disasters.  She also advised governments around the world on urgent issues such as pandemic preparedness, AIDS, antimicrobial resistance, tobacco, and cancer.

Dr. Gerberding currently serves on the Boards of CWRU, National Association of City and County Health Officials (NACCHO) Foundation, MSD Wellcome Trust Hilleman Laboratories, and the BIO Executive Committee.  She has received more than 50 awards and honors, including the United States Department of Health and Human Services (DHHS) Distinguished Service Award for her leadership in responses to anthrax bioterrorism and the September 11, 2001 attacks.  She was named to Forbes Magazine's 100 Most Powerful Women in the World in 2005 through 2008 and to TIME Magazine's 100 Most Influential People in the World in 2004.

Perry Sternberg

Perry Sternberg

EVP & Head U.S. Commercial, Shire

Read more

Perry joined Shire in 2013 and is head of Shire’s U.S. Commercial Organization. He is also a member of the Executive Committee.

Perry previously was Vice President & General Manager, U.S. & Canada Pharmaceuticals at Bausch & Lomb. Prior to that, he held various roles at Novartis Ophthalmics, Novartis Pharmaceuticals and Merck & Co., Inc.

Sheldon Koenig

Sheldon Koenig

SVP and Global Head Cardiovascular Franchise, Sanofi

Read more

Sheldon has a enjoyed a successful career of more than 25 years in various operations and marketing roles at Merck & Company and has now for the past year been with Sanofi Pharmaceuticals as Sr. VP and Head of the Cardiovascular Franchise. Sheldon has a broad range of experience in Cardiovascular marketing as well as developing product launch strategies in CV and infectious disease as well as several joint venture experiences and licensing agreements in several therapeutic areas. Sheldon received his MBA from Monmouth University and is undergraduate degree in accounting from Drexel University with post graduate and executive education studies completed at Wharton.

David Blair

David Blair

Head of Industry- Health, Google

Read more

David Blair is Head of Industry for Health at Google. He leads a team that provides thought leadership, digital marketing strategies, insights, and cross-platform advertising solutions utilizing Google’s search, content network, YouTube, mobile, programmatic and analytics platforms for the world’s leading pharmaceutical and consumer health companies. Prior to Google, David was General Manager/SVP of Provider Solutions at Everyday Health.

David began his digital career in 1997 at iVillage as Vice President of Strategic Sponsorships where he pioneered many of the first digital marketing initiatives with Fortune 500 companies including P&G, Coke, Ford, Kimberly Clark, Kellogg’s and Fuji Film. He moved into the digital health space in 2001 as SVP/Group Publisher for Johnson & Johnson’s BabyCenter.com and was SVP of Ad Sales for Revolution Health, before the merger with Everyday Health in 2008.

Blair serves on the Google Healthcare Advisory Board, was named one of the top 40 Healthcare Transformers in the US by Medical Marketing & Media in 2015 and was a juror for the 2016 Clio Health Awards. He is a frequent keynote speaker at major agencies and industry events, most recently the IMCAS World Congress; Cannes Lions Health, American Heart Association, and Cleveland Clinic’s Patient Experience Summit.

Melinda Richter

Melinda Richter

Head, Johnson & Johnson Innovation, JLABS

Read more

As Head of Johnson & Johnson Innovation JLABS, Melinda fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage. By providing infrastructure, services, educational programs and networks in global hotspots, JLABS is the best place to start a biotech company.

Prior to joining JLABS, Melinda was Founder and CEO of Prescience International, an award winning firm dedicated to accelerating research to the patient. Melinda founded Prescience after she had a medical emergency that left her questioning the efficiency and efficacy of the healthcare system. With the tenacity and resolve of a patient looking for a better solution, she set-out to create a better model, which now forms the basis for JLABS’ operational infrastructure. Prior to starting Prescience, Melinda held posts across a variety of functional areas with a global corporation, Nortel Networks, in locations such as Research Triangle Park, New York, Toronto, London, Hong Kong and Beijing before arriving in San Francisco. She also started, raised capital and did large corporate deals for several companies in both the life science and technology space. She holds a Bachelor of Commerce from the University of Saskatchewan in Canada and an MBA from INSEAD in France.

Marc Boutin

Marc Boutin

CEO, National Health Council

Read more

Marc Boutin is the chief executive officer of the National Health Council, the only organization that brings together all segments of the health community to provide a united voice for the more than 133 million people with chronic diseases and disabilities and their family caregivers.

Boutin has been a leading voice for greater patient involvement at every stage of the continuum, starting with the development of new drugs, to regulatory oversight of health care delivery, to shared decision-making at the point of care. Under his leadership, the NHC has convened a broad range of stakeholders to create and effectively implement pragmatic strategies and public policy that address diverse issues, such as enhancing patient engagement, advancing the development of new treatments, and developing a better health delivery system to meet the needs of people with chronic conditions.

Tolga Tanguler

Tolga Tanguler

Regional President, North America, Rare Disease, Pfizer

Read more

Tolga Tanguler is the Regional President, North America for Rare Diseases at Pfizer. In this role, Tolga sets forth an agenda that brings together the marketing, sales, corporate affairs and medical affairs teams to ensure they are focused on one objective: to transform patients’ lives. A key focus of the organization is to ensure that the engagement and experience of rare disease patients and their families is at the forefront of all programs.

Tolga has more than 17 years of experience in the global pharmaceutical industry, including leadership roles in both well-developed markets such as the US, Japan and the Nordics to emerging economies including Africa/Middle East and Latin America. Most recently, Tolga was the Vice President, Global Marketing for ELIQUIS. Throughout these various assignments, Tolga’s organizations were recognized for their strong growth trajectories and their colleague engagement programs.

Tolga has Bachelor of Science degrees in Economics & Finance from University of Istanbul, and a Masters of Business Administration in Marketing and Supply Chain from Michigan State University. He also has a Post Graduate Degree in Marketing from the University of California.

Andrew McCulloch

Andrew McCulloch

President, Kaiser Foundation Hospitals and Kaiser Permanente Health Plan of the Northwest

Read more

Since 2006, Andrew R. McCulloch has served as president of Kaiser Foundation Hospitals and Health Plan of the Northwest. Serving the states of Oregon and Washington, Kaiser Permanente provides medical care to over 550,000 members, along with a dental program serving over 250,000 members.

Under Andy’s leadership, Kaiser Permanente’s Northwest Region is consistently ranked as one of America’s highest performing health systems. Medicare has awarded the Northwest Region’s Medicare Advantage plan its coveted 5 Star rating for 5 consecutive years. The National Commission of Quality Assurance (NCQA) gave Kaiser Permanente Northwest’s Medicare and commercial plans the highest rating in the region in its most recent national survey results.

In the areas of customer service and community benefit, Kaiser Permanente is also recognized for its performance. In 2016— for the third year in a row — J.D. Power ranked Kaiser Permanente’s Health Plan #1 in customer satisfaction for Oregon and Washington. The Portland Business Journal has ranked Kaiser Permanente as #1 in corporate philanthropy for 2014 and 2015.

Andy received his B.A. from Wesleyan University and attended the University of Minnesota’s School of Public Health, where he received a master’s degree in Healthcare Administration. In 2015, Minnesota’s School of Public Health awarded Andy the Gaylord W. Anderson MD Leadership Award, recognizing his leadership in the field of public health. He is a Fellow of the American College of Healthcare Executives, which awarded him its Regent’s Award recognizing his contributions to the field of health care administration. In 2016, Andy was named as one of the Portland Business Journal’s top 10 ‘Executives of the Year’ for leading Kaiser Permanente Northwest’s membership growth while navigating Oregon’s health care industry.

Prior to joining Kaiser Permanente, Andy held increasingly responsible executive roles at the University of North Carolina Health Care System, UW Medicine, PeaceHealth, and Mercy Health.

Andy is also active in a number of professional and civic organizations. He has a special interest in health equity issues. He has served as a founding member of Health Share of Oregon, a coordinated care organization serving Oregon’s Medicaid population. In recognition of his leadership in transforming Oregon’s health care financing and delivery, the Oregon Business Association named him as their Statesman of the Year in 2012.

Andy and his wife, Sally, reside in Lake Oswego, Oregon.

Eddie Williams

Eddie Williams

Former SVP Biopharmaceuticals, Novo Nordisk

Read more
  • 36 years Pharmaceutical Industry experience
  • General Management Experience including P&L
  • 13+ Years of Specialty Biotech Experience
  • Bachelor’s degree in Biology/Chemistry from Marshall University
  • Advisory Board of National Sales Network
  • Chairperson of Capital Campaign of Boys & Girls Club of Trenton/Mercer for new facility
  • Board of Directors of Basic Supply Co., a small family-owned business of 35 years
  • Chair of National Hemophilia Foundation’s (NHF) Industry Advisory Panel
  • Board Member of BIO
  • Numerous internal Global Boards: Global Strategy and Commercial Boards (HSB & HCB), Global Marketing Board (GMB), Global Management Board (ManBoard), North American Executive Team (ET), Global Steering Committee for Business Development and Acquisitions
  • Executive Sponsor for Women in Novo Nordisk (WiNN)
  • Drove Franchise from $500m to $1.7B
  • All performance ratings of “Outstanding or Exceeds” by 6 different President/CEOs/SVPs over 13+ years
  • Market leadership in all 3 therapeutic areas
  • Drove 15+ year old product from 7% to > 50% share and #1 position in crowded 7-product commodity market
  • TBL: Chairperson of B&G Club fundraiser for new facility to raise $7.5M
  • Recognized as the Global “General Manager of the Year” at Novo Nordisk International GM Meeting
  • Awarded the “WE Upjohn Award“, the most prestigious global company performance award
  • Awarded “Lifetime Achievement Award“ by the National Sales Network
  • Recognized as “Industry Partner of the Year“ by National Hemophilia Foundation
  • Leadership Style and success highlighted in 2 published books by independent authors
Dalvir Gill

Dalvir Gill

CEO, Transcelerate BioPharma Inc.

Read more

Dr. Dalvir Gill currently serves as the Chief Executive Officer of TransCelerate BioPharma Inc., and its subsidiary, BioCelerate. TransCelerate is a non-profit organization with a mission to collaborate across the biopharmaceutical research and development community to identify, prioritize, design and facilitate the implementation of solutions to drive efficient, effective and high-quality delivery of new medicines, improving the health of people around the world.

Dr. Gill is a member of the TransCelerate Board of Directors, and spearheads a culture of collaboration amongst TransCelerate’s 19+ Member Companies, and an aggressive agenda that seeks to advance innovation in R&D, identify and solve common R&D challenges and further improve patient safety, with the goal of delivering more high quality medicines to patients.

Prior to his appointment as CEO of TransCelerate, he was the President of an international contract research organization. Dr. Gill earned his BSc in Applied Biology from the University of Hertfordshire and his PhD in Pathobiology from the Royal Free Hospital School of Medicine, University of London. He also holds a diploma in the Health Economics of Pharmaceuticals from the executive program of the Stockholm School of Economics. Dr. Gill has presented his research and spoken at numerous conferences, and has authored more than 30 scientific publications. He also is an elected fellow of the Royal Society of Medicine.

Patrick Desbiens

Patrick Desbiens

Senior Vice President US Vaccines, GSK

Read more

Patrick Desbiens leads GSK’s vaccines business in the US, bringing more than 25 years of industry insight. Patrick joined the US business in 2015 after serving as President of GSK France for nearly 3 years, overseeing the Pharma and Vaccines businesses and all GSK operations there. Previously he led the Sales & Marketing pharma teams in France and also served as General Manager for GSK Romania. A native French speaker from Montreal, Patrick started his career as a pharma rep with Eli Lilly-Canada before joining GSK Canada in 1996 where he worked across several functions in sales, marketing, communications, market access and public affairs.

Paul Darling

Paul Darling

Principle, ZS Associates

Read more

Paul Darling is a principal with ZS in the San Francisco office. Paul assists life sciences companies in evaluating new markets, acquisitions and licensing opportunities, as well as developing new go-to-market strategies. He has published and presented on these topics.

Paul leads ZS's institute on U.S. Healthcare Evolution and Scenario Planning. His work explores strategies for life sciences companies to take a broader role in patient health in the era of U.S. healthcare reform. This includes new business models, therapies, acquisitions, partnerships, and reimagining the commercial model to support such strategies.

Prior to joining ZS, Paul was a fellow at the Perelman School of Medicine at the University of Pennsylvania. He holds a B.S. in biochemistry from Boston College and a Ph.D. in statistical thermodynamics from Washington University.

Pratap Khedkar

Pratap Khedkar

Principle, ZS Associates

Read more

Pratap Khedkar is a managing principal in ZS’s Philadelphia office, and leads the firm’s global pharmaceuticals and data science practices. He has advised many biopharmaceutical and healthcare companies on a wide range of business issues including commercial strategy, customer-centric marketing, market access, sales compensation and advanced analytics.

A recognized healthcare industry expert, Pratap regularly contributes his insights to publications including The Wall Street Journal, Bloomberg Businessweek, Business Insider, Fortune, Medical Marketing & Media, NPR, Pharmaceutical Executive and others. Currently, his thought leadership work focuses on topics including healthcare policy; life sciences companies’ new commercial and organizational models; and the evolving relationships between patients, providers and payers, and the life sciences organizations that serve them.

Pratap holds a B.S. in computer science from the Indian Institute of Technology, Delhi, and a Ph.D. in computer science from the University of California at Berkeley.

Reagan Tully

Reagan Tully

VP, Strategy and Marketing, McKesson

Read more

Reagan Tully brings over 18 years of experience within the pharmaceutical industry in multiple therapeutic categories, including oncology, virology, vaccines, cardiovascular, respiratory and dermatology. She has led sales, operations, marketing and commercial strategy for multiple top 10 manufacturers, including products from clinical development through end of lifecycle. Currently she serves as VP of Strategy for McKesson Specialty Health, within a division that specializes in manufacturer solutions.

Jonathan Barrett

Jonathan Barrett

VP Oncology Marketing, EMD Serono

Read more

Jon Barrett is the VP of Oncology Marketing for the US business at EMD Serono. He has worked in the Pharma industry for over 27 years, 21 of those years spent in Oncology. Jon is primarily focused on developing and implementing successful US launch strategies for the company’s oncology portfolio.

Prior to EMD Serono, Jon has worked at several oncology companies in Global, US and UK roles, including AZ, GSK, Sanofi and Eisai.

Jon grew up and was educated in the UK. He holds a BSc from the University of Southampton and lives with his family in Flemington, NJ.

David Fortanbary

David Fortanbary

Head of US Performance Training, UCB inc.

Read more

David has 30 years of Pharmaceutical and Biotech experience in a multitude of commercial roles in sales, sales leadership, marketing, market access, medical groups and learning and development.  Currently, David is the Head of Performance Training at UCB Pharmaceuticals, a global organization that is inspired by patients and driven by science.  In his role, David leads a team dedicated to bringing value to patients by enabling commercial teams to effectively engage with stakeholders who are a part of the patients’ journey in serious neurological and immunological diseases.  David is also the current Vice-President of LTEN – a Life Science Trainers and Educators Network.

Jay Graves

Jay Graves

Vice President of Sales, Roche Diabetes Care

Read more

Jay is responsible for leading the U.S Professional Sales organization to include, the HCP Sales Force, Inside Sales, Global Pharma Trials, Sales Training, and Operations. Since joining Roche in 2006, Jay has held several positions within Diabetes Care to include Physician Field Sales Representative, Region Business Manager – Health Care Provider, Region Business Manager – Managed Care, Retail and Distribution, Area Business Director for the Central and Western US and Region Marketing Director for Blood Glucose Portfolio.

Jay began his professional career in 1998 as an Intelligence Officer in the United States Army. In the Army, Jay held multiple leadership positions and global deployments including tours in South America, Central America, The Caribbean, South Korea, The United Kingdom, Jordan and Iraq. After leaving the Army, Jay worked as a Field Sales Representative in Sanofi-Aventis’ Metabolism Division before moving to Roche Diabetes Care.

A native of Raleigh, N.C., Jay earned a bachelor’s degree in Political Science and Military Science from North Carolina State University and is currently enrolled in the Executive MBA program at the University of North Carolina at Chapel Hill.

Kasia Hein-Peters

Kasia Hein-Peters

Vaxelis (PR51) Marketing Head, Sanofi Pasteur

Read more

Trained as medical doctor, innovation consultant and executive coach, Kasia Hein-Peters, MD has more than 20 years of experience in pharmaceutical industry, in both developed and emerging markets. She specializes in launching new medicines and vaccines, managing product life-cycle, and developing integrated stakeholder engagement campaigns. Through mentoring and coaching, Kasia builds highly performing, diverse teams. She likes speaking on global brand management, multicultural marketing and human-centric approach in pharma marketing. Currently, Kasia is preparing launch of a new hexavalent vaccine as a Marketing Head of MCM Vaccine, a joint-venture between Sanofi Pasteur and Merck & Co., Inc./MSD.

John Jacoppi

John Jacoppi

Executive Director- Marketing, Sunovion

Read more

John Jacoppi is Executive Director, New Products Planning at Sunovion Pharmaceuticals, Inc. He recently served as Executive Director, Psychiatry Marketing, where he launched a comprehensive DTC campaign in support of Latuda®. He brings over 27 years of pharmaceutical experience and has worked at Johnson & Johnson and Astra Zeneca in various roles. John brings a wealth of successful commercial experiences including positioning, segmentation, customer loyalty, patient-centricity and a full range of marketing/life cycle management activities. He holds a Bachelor of Arts Degree from University of Pennsylvania and a Masters in Management from Northwestern University's Kellogg School of Management.

Kobi Gershoni

Kobi Gershoni

Co-Founder & Chief Research Officer, Signals

Read more

Prior to co-founding Signals, Kobi was a Senior Analyst and Information Officer for an elite intelligence unit in the Israel Defense Forces, where he began to contemplate and refine the incorporation of open source intelligence into the growth plans of consumer brands and innovation agendas of life sciences companies. Kobi holds an MBA in Finance and Strategy as well as a BA in International Relations from Hebrew University in Jerusalem.

Mike Gianelli

Mike Gianelli

Director, Acquia

Read more

Michael Gianelli is the Director of Acquia's Healthcare practice. He has helped organizations like J&J, Roche, and Novartis transform their approach to digital to meet the ever changing needs of patients, doctors and healthcare providers. 

Heidi Floyd

Heidi Floyd

Author/Patient/Advocate/Speaker

Read more

As individuals are diagnosed with cancer, many immediately seek to make a connection with others for help.  Heidi Floyd has become that resource for many. As an author/speaker/patient/advocate, she is able to lean on myriad of NGOs and fellow patients in her network. Heidi has the ability to lean in and listen to true needs – from caregivers and corporations who want to help, but aren’t sure where to begin. Connecting those who need with those who can assist is her true passion, and has done so worldwide. She’s addressed venues as varied as Google to classrooms of 6.

Jim Demaioribus

Jim DeMaioribus

Vice President, Marketing, Aqua Pharmaceuticals

Read more

Jim DeMaioribus is Vice President of Marketing at Aqua Pharmaceuticals, an Almirall Company. While many are awakening to social media, Jim has helped businesses capitalize on the opportunities created through this unique and diverse medium for nearly a decade.

Jim has had significant success in identifying new business opportunities across 200 companies where technology can serve as a new revenue generating opportunity or to add value to an existing product portfolio.

José Ignacio Rasco

José Ignacio Rasco

CEO, .health

Read more

José Ignacio Rasco is the Chief Executive Officer and founder of dotHealth, where he is responsible for the company’s vision, strategy and growth. Previously, José Ignacio was a co-founder and the Chief Financial Officer for the .CO registry. As part of the .CO team, José Ignacio helped grow the registry from 30,000 to 1,000,000+ domains in less than one year. Today, .CO is a mainstream domain with 2,000,000+ domains registered. He and his co-founders sold .CO in 2014 to Neustar, a public company and the largest provider of core registry and digital naming services. José Ignacio also serves as Managing Director of STRAAT, a Miami-based company that builds innovative companies including BUILDING.co and Classic.com.

Prior to José Ignacio's work in the registry and domain business, he worked in public accounting with varied industry experiences in audit and assurance services. He is a Certified Public Accountant in the State of Florida and holds a Bachelors of Science degree in economics from the Wharton School of the University of Pennsylvania and a Master’s degree in taxation from Florida International University.

Ed Chase

Ed Chase

Business Line Leader, Life Sciences, Pegasystems

Read more

More information coming soon...

Ashkan Afkhami

Ashkan Afkhami

VP & GM, Healthcare, Mobiquity

Read more

More information coming soon...

Mike Welsh

Mike Welsh

Chief Creative Officer, Mobiquity

Read more

More information coming soon...

Anthony Yanni

Anthony Yanni

Global Head, Medical Intelligence and Patient Perspectives, Sanofi

Read more

Anthony J. Yanni, MD, MBA currently serves as Head, Medical Intelligence and Patient Perspectives for Sanofi Global R&D. Dr. Yanni is a graduate of Drexel University School of Medicine in Philadelphia, Pennsylvania and received an MBA from the University of Massachusetts. He completed a 3 year Residency in Internal Medicine for which he was Board Certified in 1995 and recertified in 2005. Following his specialty training, Dr. Yanni practiced clinical medicine for 12 years and while in practice served as Chief, Internal Medicine at a hospital system in Pennsylvania. He later served as Chief Medical Officer in the same system.

After leaving clinical practice, Dr. Yanni began his career in the pharmaceutical industry with Sanofi Pasteur, working as a Director, Clinical Development where he managed the development of protocols and execution of clinical trials for vaccines. He also worked with teams in the evaluation of external opportunities. From Sanofi Pasteur, Dr. Yanni moved to Sanofi where he served as Senior Director, Translational Medicine and Clinical Development where he focused on the identification of Medical Value and Patient Need in targeted indications. He began his current role, Global Head, Medical Intelligence and Patient Perspectives in 2013.

While at Sanofi, Dr. Yanni co-led the development of the Patient Engagement Portal and continues to lead R&D efforts in developing and operationalizing meaningful patient engagement in research.

Kate Gordon

Kate Gordon

Policy Advisor, Alzheimer’s Disease International

Read more

Kate Gordon is a Policy Adviser for Alzheimer’s Disease International where she provides public policy and campaign guidance, focusing on work with the Pan American Health Organization.She is a skilled health policy analyst and grassroots advocacy strategist with more than 15 years of experience working in the fields of health and long term care. Her expertise includes policies affecting persons with dementia, caregiver interventions, and direct care worker training. Kate’s previous work includes collaborating with multiple federal entities and state and community-based agencies to connect older adults with easy, actionable opportunities for clinical trial research participation.

Kate Zhong

Kate Zhong

Chief Strategy Officer, Global Alzheimer’s Platform

Read more

Dr. Kate Zhong is the Chief Strategy Officer for the Global Alzheimer’s Platform (GAP), a foundation devoted to improving and accelerating clinical trials for Alzheimer’s disease. Dr. Zhong leads the organization’s strategic planning, marketing and branding effort, patient recruitment and engagement, technology development and alliance.

Prior to this role, Dr. Zhong was the Senior Director of Clinical Research and Development for the Cleveland Clinic Lou Ruvo Center for Brain Health, which has been established as one of the largest and most active clinical trial facilities for memory disorders in the country; with more than 60 drugs and diagnostic trials being conducted at the Center.

Dr. Zhong received her MD degree from West China University of Medical Sciences in Sichuan, China. She earned her Master Degree in Pharmacology and completed her residency in Psychiatry at University of Toronto, Canada. As a Geriatric Psychiatrist, Dr. Zhong has extensive experience in providing treatment and care for patients with neurocognitive disorders. While working as the Medical Director and Seroquel Brand Global Physician for one the world’s leading pharmaceutical companies, Dr. Zhong led multiple global clinical trials in CNS therapeutic areas including Alzheimer’s disease, Parkinson’s disease, schizophrenia, and mood disorders.

Dr. Zhong has been a scientific consultant for multiple pharmaceutical, biotech, and patient recruitment companies. Dr. Zhong has provided multifaceted services to industry, academic centers, and health care institutions in the United States, Canada, and Asia. Dr. Zhong works closely with patient advocacy groups, philanthropic organizations, private foundations, and technology companies. She is actively engaged in public education and community activities involving clinical research, healthy aging, and brain wellness.

She serves as one of the founding members of WomenAgainstAlzheimer’s and is a member of International Women’s Forum. She was honored as a “Woman to Watch” and” Alzheimer’s Ambassador” by Vegas Inc. Magazine. She was featured in the PBS documentary “MAKERS: Women Who Make America,” profiling her as one of Nevada’s most influential women. She was recently honored with the Las Vegas Top Tech Exec Award and Healthcare Headliner Research Award for her creation of Cleveland Clinic healthybrains.org, an innovative interactive digital platform to accelerate clinical trial enrollment and to engage the community to become involved with a brain healthy life style.

Teresa Bitetti

Teresa Bitetti

SVP, Head US Oncology, Bristol-Myers Squibb

Read more

Teresa Bitetti is the Senior Vice President and Head of U.S. Oncology at Bristol-Myers Squibb. In this role, she leads the strategy and commercial operations for the U.S. Oncology organization. Under her leadership, Bristol Myers Squibb Immuno-Oncology agents in the U.S. Market has grown exponentially with the launch of two new drugs, Opdivo and Empliciti, increasing the Oncology portfolio to 11 indications across 6 tumor types in less than three years. She strives for excellence in commercial execution, and encourages her teams to deliver multi-pronged, innovative approaches to reach patients.

Prior to this appointment, Teresa was the President and General Manager of Bristol-Myers Squibb Canada where she was responsible for commercial operations across the entire portfolio.

Ms. Bitetti joined Bristol-Myers Squibb in 1996 and has successfully led teams across multiple therapeutic areas and functions. Some of her key leadership roles include, Vice President, Virology, Global Commercialization; Vice President, Neuroscience National Sales; Vice President, Neuroscience Marketing; and Regional Vice President for the Northeast Sales Region.

Prior to joining Bristol-Myers Squibb, Teresa held various roles of increasing responsibility at Mobil Oil Corporation where she was part of the Capital Markets Group and was responsible for the investment of Mobil's worldwide pension assets.

Over Teresa’s 20 year career, she has been highly recognized for her adept ability to mobilize teams to deliver exceptional performance. Her notable awards include Medical Marketing Association 2003 Pharmaceutical Marketer of the Year Award and Medical Marketing & Media 2016 Hall of Femme Honoree.

Teresa holds a BA in Classical Civilization from Wellesley College and an MBA in Finance from Darden School of Business at University of Virginia.

Paul Harney

Paul Harney

Vice President, Solutions Design, North America, Integrated Engagement Services, Quintiles IMS

Read more

Paul Harney has joined QuintilesIMS as Vice President, Solutions Design, North America, Integrated Engagement Services. For more than 18 years, Paul has served the healthcare and life sciences industry with advice, guidance, and business support. He has engaged biopharmaceutical companies in nearly all functional areas including Sales, Marketing, Medical Affairs, Business Development, and Supply Chain. Paul draws on specific expertise in strategy, communications, operations, and analytics at the brand/franchise, division, and corporate levels to identify opportunities to increase value. His extensive experience with retail and institutional products covering several therapy areas such asdiabetes, respiratory, anti-infectives, urology, vaccines, and dermatology allows him to quickly leverage best practices and initiatives that enhance go-to-market strategies.

MarlaJan Wexler

MarlaJan Wexler

Patient, Lupus Advocate and Blogger, Luck Fupus

Read more

MarlaJan Wexler is 35 years old, was born with a complex congenital heart defect, and had 4 open-heart surgeries by the time she was 6. She went from pediatric cardiac ICU patient to pediatric cardiac ICU nurse until being diagnosed with systemic lupus erythematous (lupus). Due to complications from the disease, she was forced her to give up her nursing career. Since 2008 she has been diagnosed with lupus and multiple overlapping autoimmune diseases, cervical cancer, and underwent a double mastectomy December 2014 after a lump was found in her breast.

She’s the creator and author of the blog Luck Fupus (www.luckfupus.com) which she writes about the day-to-day and long-term struggles of living with multiple chronic illnesses. She’s know for her humorous, non-sugar coated, keep-it-real style of writing. Her blog was used as a platform to help her become a patient leader and influencer, and she now travels the country attending healthcare conferences, speaking publicly sharing her story, educating and advocating for patients across the globe.

Email - luckfupusblog@gmail.com
Blog - Luck Lupus www.luckfupus.com
Twitter - @marlajan
Facebook - www.facebook.com/luckfupusblog
Instagram - @marlajan
Pinterest - marlajan81

Jeffrey Rohwer

Jeffrey Rohwer

Co-Founder, Sentient

Read more

More information coming soon...

Anthony (Tony) J Schueth

Anthony (Tony) J Schueth

CEO & Managing Partner, Point-of-Care Partners

Read more

Anthony Schueth, MS, is the CEO and Managing Partner of Point-of-Care Partners (POCP), a health information technology (HIT) strategy and management consulting firm specializing in the evolving world of electronic health records. A 25-year healthcare veteran, he is an expert in HIT, in general, and one of the nation’s foremost experts in ePrescribing and eMedication Management. In addition, he previously served as a co-leader of NCPDP’ Specialty ePrescribing Task Group and leads the NCPDP Electronic Prior Authorization Task Group. Mr. Schueth has led numerous transformative industry initiatives, including the highly successful Southeastern Michigan (SEMI) ePrescribing Initiative.

Nicole Mowad-Nassar

Nicole Mowad-Nassar

Vice President External Partnerships, Takeda

Read more

Nicole Mowad-Nassar is the Vice President of External Partnerships at Takeda Pharmaceuticals, a leading international pharmaceutical company. Her years of commercial experience span multiple key responsibilities in sales and marketing, as well as operations and analytics. An accomplished general manager who has successfully overseen integrated functions, Nicole possesses core competencies that include proven alliance management expertise. She leverages her broad understanding of the pharmaceutical industry to best identify opportunities in Takeda’s business to enhance the patient journey and answer key clinical questions via big data and digital innovations.

As Vice President of External Partnerships, Nicole is pioneering the company’s efforts to pursue innovative and game-changing technology collaborations. She is charged with identifying the linkages between the healthcare/pharmaceutical and technology sectors. Her extensive background in the pharmaceutical industry has proven essential in this capacity - knowledge of healthcare procedures and best practices is vital in order to improve relationships between patients, technology entrepreneurs and healthcare providers.

Nicole Mowad-Nassar has more than 20 years of experience in the pharmaceutical industry. Prior to joining Takeda, Nicole served as Divisional Vice President and General Manager, U.S. Primary Care Sales and Marketing for Abbott Laboratories. In that capacity, she led a team of over 2,500 sales and marketing professionals and gained acquisition integration experience. While at Abbott, she also held several Vice President and general management positions in a number of therapeutic areas of both hospital products and pharmaceuticals. Nicole also brings sales and marketing experience from TAP Pharmaceuticals, a former joint venture between Takeda and Abbott.

During her tenure with Takeda, Nicole Mowad-Nassar has launched over 11 products in recent years and accepted a leadership role as a member on several steering committees dedicated to developing partnerships between Takeda and other companies. Nicole was distinguished as an Emerging Leader by Pharmaceutical Executive in 2011, and she received the Takeda Global Award in 2010 in recognition of her outstanding achievements at Takeda. In 2005, she was named an HBA Rising Star.

Laura Barry

Laura Barry

Senior Director Customer Insights, Analytics and Experiences, AbbVie

Read more

Laura Barry is Senior Director, U.S. Insights, Analytics and Customer Experiences. She is responsible for Marketing Operations encompassing Digital, CRM, Media, Promotional Operations, Marketing Training, as well as Marketing Analytics and Business Insights for U.S. Commercial which represents 62% of the $25.6 Billion AbbVie Inc. Laura is fairly new to Pharma, and joined Abbott, now AbbVie prior to the split in February, 2012.

Laura joined AbbVie five years ago to lead the Market Analytics and Business Insights team. Laura has been a key leader in driving AbbVies’ Consumer Centricity and developing core capabilities in insight discovery, patient journey, comprehensive analytics and influencing AbbVies’ business optimization. Over the past five years her responsibilities have expanded to include Marketing Operations where she has set out key initiatives in Digital Transformation in partnership with line businesses in creating connected customer experiences.

Prior to AbbVie, Laura spent a rewarding 21 year career at Kraft Foods. Most recently she held position of Vice President, Shopper Insights and Category Leadership, Kraft, North America. Prior to this position, Laura was Vice President, Consumer Insights and Strategy, Kraft, North America. Laura is a committed member of the marketing community and a member of Rutgers MRIA Board, IMS Strategic Board, MSI Trustee, and HBA.

Mark Baglin

Mark Baglin

Vice President of Global Marketing, Alnylam Pharmaceuticals

Read more

Mark has been Vice President, Global Marketing for Alnylam Pharmaceuticals, based in Cambridge, MA, since February 2017. Originally from the UK, he has over 25 years’ commercial and franchise leadership experience within global healthcare organizations, living for the last 20 years in the US. He has successfully built teams and delivered results for global and US companies in Pharmaceutical, Biotechnology and Medical Device spaces in both pre- and post-launch environments. Before joining Alnylam, Mark had held positions of increasing seniority within GSK, AstraZeneca, Johnson and Johnson and, most recently, Shire Pharmaceuticals where, as Vice President, Product Strategy Team Leader, he was responsible for building a $1bn+ portfolio of products in the Hereditary Angioedema rare disease space. When not working, Mark enjoys keeping fit and running around after his family. Not unrelatedly, he also enjoys climbing into caves, jumping from airplanes and riding dangerous motorcycles.

David Lennon

David Lennon

VP & Franchise Head – US Oncology, Novartis

Read more

Dave is the VP & Head, Oncology Solid Tumors Franchise in Novartis’ US Oncology. He joined Novartis Pharmaceuticals in 2005 based in Basel, Switzerland as Head of New Products and Portfolio Strategy and later Global Business Franchise Head of Immunology and Infectious Diseases. He has assumed positions of increasing commercial responsibility, most recently spending 3 years in Shanghai, China, as Chief Marketing Officer and Head, Cardio-Metabolic Business Unit.

Prior to joining Novartis, Dave’s work focused on pharmaceutical R&D Strategy, M&A and business development at McKinsey & Company rising to Associate Principal.

Dave attended Columbia College as an I.I. Rabi Scholar majoring in Biophysics. In 2001, he completed his PhD at Weill Medical College.

Christopher Pitcherella

Christopher Pitcherella

Director, Clinical Trial Innovation | Global Clinical Operations, Teva

Read more

Chris is currently the Director of Clinical Trial Innovation within the Teva’s Global Clinical Operations organization sitting within the Global Specialty Development division of Teva. Chris’ main accountabilities are being a key driver, influencer, and accelerator of clinical trial innovation opportunities. Chris provides focused efforts on leading transformational opportunities regarding the use of healthcare data and technologies that offer novel approaches to clinical trial design, feasibility, recruitment, trial operations, site and patient centricity, quality oversight, and overall execution of clinical trial programs. Chris has over 17 years of experience in pharmaceutical development, progressing through diverse roles of increasing responsibility in the areas of clinical operations; strategic sourcing & procurement; project management; and alliance management. Chris has a BS in Business Marketing and an MBA with a concentration in Management Information Systems from Stockton University, as well as an MS in Clinical Research Organization and Management from Drexel University.

Joshua Palau

Joshua Palau

Sr. Director Digital Innovation, Social Media and Search, Johnson & Johnson

Read more

Joshua is the Sr. Director of Global Partnerships for Johnson & Johnson’s Global Marketing Solutions group. In this role he leads the global partnerships with Google, facebook, and creative agencies to ensure brands are effectively leveraging these platforms and deliver the best experiences. Prior to J&J, Joshua spent 4 years as the VP of Marketing and e-commerce for Comcast and 6 years at Razorfish as the VP of Search Marketing.

In his spare time, he’s an adjunct professor at Temple University, serves as an advisor for the AdCouncil and volunteers for The St. Baldrick’s Foundation whose focus is funding research for childhood cancers.

Joyce Ercolino

Joyce Ercolino

Digital Business Leader & Strategist

Read more

Joyce Ercolino was formerly Head of Digital Communications at CSL Behring, where she led the enterprise to embrace digital transformation and customer experience excellence. Joyce established and matured digital marketing and social media across CSL through advocacy, education and tenacity.

As Director of eStrategy in Global Commercial Development, she was responsible for digital and social media strategy, and established and chaired two global cross-functional teams to support compliance and knowledge sharing.

Joyce combines marketing and technology expertise to deliver patient and product marketing programs. She shares her passion for digital healthcare to create meaningful relationships with customers.

Bob Cannon

Bob Cannon

Chairman and CEO, Eagle Productivity Solutions

Read more

Bob Cannan is CEO of Eagle Productivity Solutions, the leading provider of training and business process solutions for the pharmaceutical industry. Eagle has offices in the U.S., the U.K. and Spain, and has delivered effective training in more than 40 countries and 20 languages.

Bob subscribes to Steve Jobs’ philosophy that, "Man is the creator of change in this world. As such he should be above systems and structures, and not subordinate to them.”

For more than 20 years, Eagle has been helping companies remain “above” systems and structures, evolving with their tools instead of falling subordinate to them. As tools and technology continue to change, Eagle’s high-adoption training helps companies keep up.

David Reim

David Reim

Chief Product Officer, DMD

Read more

David Reim invented the Internet in 1993. In 1995 he led the team that launched www.Claritin.com, the first branded pharmaceutical website. He followed that with several decades of wandering around the new rain forest of digital marketing, accompanied by a troop of hairless albinos. Now he finds himself at EyeForPharma. No one is as surprised as him.

Will Reese

Will Reese

President Cadient & Chief Innovation Officer, Cognizant Life Sciences

Read more

Will Reese leads the creative and innovation teams in identify emerging trends and crafting customer experiences. Will is a frequent speaker and writer on the healthcare customer experience, content marketing, and digital disruption. Will brings more than 17 years of healthcare industry experience, providing strategy, user experience, and creative consulting for major healthcare, life science, OTC, medical device, and biotech clients. He has worked across a wide variety of therapy areas including women’s health, oncology, cardiovascular, and neuroscience. His industry expertise has led him to develop award-winning programs and first of their kind experiences for industry leading clients and brands. Will has extensive experience in innovation consulting, launching new products, integrating emerging technologies, and designing new approaches to the commercial model.

Patrick Richard

Patrick Richard

Managing Director Data Science, inVentiv Health Communications

Read more

As Managing Director of Data Science for inVentiv Health Communications, Patrick partners with agency teams to build and implement unique offerings in the predictive analytics, strategic planning, and measurement space. Patrick’s experience building award-winning marketing platforms for some of the world’s most recognized companies and his diverse background in retail, e-commerce, travel, consumer, and healthcare allow him to bring diverse expertise and strategic guidance to business challenges. Prior to inVentiv Health Communications, Patrick developed digital platform strategies that defined effective ways to approach the digital consumer experience for companies such as Orbitz.com and Sears Holdings Online Services.

Leigh Householder

Leigh Householder

Managing Director of Innovation, inVentiv Health Communications

Read more

As Managing Director of Innovation for inVentiv Health Communications, Leigh is responsible for shaping the company’s perspective on the next era of healthcare marketing. Through thought leadership, strategic innovation workshops and new products and capabilities, Leigh focuses on identifying marketing approaches that will fuel that new era and generate significant growth for clients. Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for nearly two decades, and has worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Every year, Leigh convenes a group of trend watchers from across inVentiv Health’s global network to identify the shifts most critical to healthcare marketers.

Robert Palmer

Robert Palmer

EVP, Managing Director, Juice Pharma Worldwide

Read more

Robert Palmer is EVP, Managing Director at Juice Pharma Worldwide. He has over 15 years of DTC and HCP pharmaceutical experience. Before joining Juice Pharma in 2010, Robert was Managing Partner at Sudler & Hennessey, overseeing Sudler’s digital practice. Prior experience includes Managing Director of Tribal DDB New York, where he founded Tribal’s healthcare practice with the online DTC consumer launch of AbbVie’s blockbuster HUMIRA. He has also been a Partner at Rosetta, where he specialized in attitudinal segmentation and CRM. Robert is presently on the Advisory Board of the Digital Health Coalition, a member of the Programmatic Health Coalition, and is Chairman of the Medical Advertising Hall of Fame.

Matt Kollmorgen

Matt Kollmorgen

Vice President of Digital Transformation Group, Soft Serve

Read more

Matt Kollmorgen is a Vice President in SoftServe’s Digital Transformation Group, focused on helping companies innovate their digital experience and customer engagement strategies.

Matt is a digital strategist with an enterprise technology focus. He brings a wealth of experience across digital agency and corporate environments and has contributed to many enterprise digital transformation initiatives.

His experience in the Pharma industry includes projects for Johnson & Johnson, Sanofi, Pfizer, and Sharp Healthcare. He possesses a unique appreciation for the user experience design process along with keen understanding of digital technologies, user experience, and data platforms.

Matt participates directly in client’s experience design workshops and strategy sessions, sharing his insights and experiences at various industry events and conferences.

Joan Arata

Joan Arata

Senior Vice President, Everyday Health Professional

Read more

Joan is a Registered Nurse, who, after practicing clinically in adult medical intensive care, moved into medical communications. The majority of her career has been focused on medical education and communications to health care practitioners (HCPs).

Joan was Managing Director of a medical education communications company that she acquired and, ultimately sold to Publicis Health. Once she completed this transaction, Joan went to Medscape CME, where she was recruited to build the newly created Medscape CME sales organization to meet the firewall requirements of separating promotion from CME.

Joan joined Everyday Health in June, 2015. Joan is SVP of the Everyday Health Professional sales organization where she leads a team that spans from Sales Strategy to Field Sales, to Post-Sales Execution. This team works in partnership with Pharma and Biopharma and their agencies to drive strategies to increase conversations with healthcare professionals that, ultimately lead to improved patient care.

Joan is a leader in recognizing trends in HCP communications and education, and as such, frequently moderates panels and discussions at major industry events focusing on these topics.

Nisith Kumar

Nisith Kumar

Director- Global Patient Affairs, Pfizer

Read more

Mr. Kumar is a Director of Global Patient Affairs (GPA) which is accountable for driving end to end patient centricity across Pfizer. In this role, Mr. Kumar co- leads an initiative to drive patient centricity within Pfizer’s Global Product Development team. External leadership roles include co-leading a TransCelerate initiative to increase the awareness of clinical trials in the public domain. Mr. Kumar also has Pfizer operational responsibilities that include among others, goal alignment, budget management, GPA’s Goals Dashboard updates, and Op Planning and running specific projects such as the Bioethics Advisory Panel, Multi-Company initiatives, and leading the OWNers team, a change management initiative within Pfizer Medical. Prior to this role, Mr. Kumar was a Director of Project Management for the office of the Chief Medical Officer.

In this role, he served as the point of accountability for assuring all projects within CMO’s office were prioritized, had clear tangible deliverables and adhered to a project plan. His responsibilities were to assure there was adequate follow up and guidance with the key strategic initiatives; so, that they were tracked and delivered on time. Mr. Kumar has a broad background in the operational delivery of clinical trials. Moreover, his unique skill set of being able to collaborate across functions, companies and cultures, strong leadership experience from running cross-functional study teams and his knowledge of project management disciplines served him well to monitor and drive the vast array of initiatives. Mr. Kumar started his career at a small CRO (Coromed, now part of Omnicare) as a CRA in 1995. After a brief role as a PM, he joined Pfizer in 1998 as a Study Manager with the World Wide Aricept Team and switched to another co-promoted product, Rebif in 2003. In his most recent position as a Clinical Project Manager (operational lead within DevOps), he led several study teams for Lipitor, Lyrica and Apixaban.

Ramana Sonty, MBBS, PhD.

Ramana Sonty, MBBS, PhD.

Director, Global Medical Organization, Johnson & Johnson

Read more

More information coming soon...

Ann Kwong

Ann Kwong

CEO & Founder, TREK Therapeutics

Read more

Ann Kwong is an internationally recognized industry leader in antiviral drug discovery and development and the co-founder and CEO of Trek Therapeutics. Trek is committed to developing affordable and accessible drugs to treat infectious diseases globally. Trek is conducting Ph2 clinical trials to develop a potentially best-in-class, ultra-short (4-6 week) HCV regimen to cure patients infected with HCV genotype 1 (GT1). Prior to Trek, Ann founded the infectious disease group at Vertex Pharmaceuticals and played a leading role in the discovery, development, and commercialization of telaprevir (INCIVEK™), a HCV protease inhibitor with >$1B in revenue in its first year.

Roslyn Schnider

Roslyn Schnider

Global Patient Affairs Lead, Pfizer Medical

Read more

Roz is the Global Patient Affairs (GPA) Lead within Pfizer’s Chief Medical Office. Roz’s team drives more systematic, end to end patient centricity at Pfizer. She received her BS from the Sophie Davis School of Biomedical Education of the City College of New York, MD from Mount Sinai School of Medicine, and MSc in Pharmaceutical Medicine from Hibernia College. A retired Clinical Professor of Medicine of Albert Einstein College of Medicine, an Internist, Pulmonologist, Intensivist, she practiced for twenty years. She published in the areas of pulmonary complications of HIV infection, venous thromboembolic disease, medical ethics and medical education.

Jamie Burks

Jamie Burks

Patient Experience Lead, Patient Value Unit, UCB

Read more

More information coming soon...

Liza Maricle

Liza Maricle

RN, Right Start Nurse Educator

Read more

More information coming soon...

Susan Garfield

Susan Garfield

Principle, EY

Read more

Dr. Garfield heads up the Commercial Strategy and Market Access function within the Life Science Advisory practice. She helps life science companies optimize the value propositions, maximize launch opportunities, transform commercial models, and drive customer centricity. Previously, she was Executive Vice President, Healthcare Consulting Services at GfK. She led their US Market Access practice which spanned pharma, biotech, medical device, diagnostic and specialty pharma clients.

Prior to that Dr. Garfield ran global market access, pricing, and health economics at QIAGEN, focusing oncology and precision medicine (previously Digene). After graduate school, Dr. Garfield held various consulting roles at Boston Healthcare Associates, leading their Commercial and Health Economics practice after a 6 year tenure at the firm. Dr. Garfield has published numerous articles, chapters and a book on healthcare payment issues, also having multiple speaking engagements and poster sessions at industry and academic conferences.

Dr. Garfield holds a Doctorate of Public Health from Boston University, a Master of Science Health Policy and Management from Harvard University, a Master of Science in Population and Development from London School of Economics, and a Bachelor of Arts from the University of Pennsylvania.

Maryellen Royle

Maryellen Royle

Global CEO, Tonic Life Communications

Read more

Maryellen Royle is a respected public relations strategist who has partnered over the past 20+ years with leading global organizations in pharma, biopharma, device and diagnostics, and consumer products. She is a natural leader who attracts top talent to Tonic. Maryellen forms lasting relationships with her clients and colleagues, bringing them the benefit of her experience and innovative ideas to deliver success. Maryellen is honored to have been recognized for her industry contributions, being named among the “Top Women in PR” by PR News and featured in PharmaVOICE 100. She resides in Wayne, PA with her husband and three daughters.

Peter Sandor

Peter Sandor

TA Head Oncology Marketing Strategy, Astellas

Read more

Peter Sandor Vice President, Head of Oncology Therapeutic Area Marketing Strategy. In this role, Peter provides commercial leadership for project’s within the oncology therapeutic area and plays an integral role in the expansion of Astellas’s presence in oncology

Peter has 20 years of progressive marketing experience. He was recently the Vice President, Global Marketing Oncology at Amgen responsible for the successful realization of the commercial potential for Amgen’s oncology assets. Prior to Amgen, he has held different positions at Bayer Healthcare, including Head of Strategy and Portfolio Management Specialty Medicine, Commercial Development and Life Cycle Management Global Oncology. He also worked for Berlex Laboratories as the lead of the global launch team for a key oncology compound, and held multiple marketing roles with Schering AG in Germany and Hungary.

Peter started his career in bench research as a scientific advisor of the Hungarian Academy. He received his MDS Marketing and MBA from Middlesex University, London and Faculty of Business and Economy, University of Pécs, Hungary, and his MD from University of Pécs, Hungary.

Chris Sellin

Chris Sellin

Head of Operational Excellence & Analytics, Shire

Read more

Christopher Sellin is currently the Head of Operational Excellence & Analytics at Shire. Prior to this role, he cultivated broad pharmaceutical knowledge via Sales Management, Marketing, Analytics and Operations roles at Baxalta, Novartis and Eli Lilly. Chris is a certified Lean Six Sigma Black Belt who has worked on developing effective Sales and Marketing processes and frameworks within US and Global organizations. He graduated from Temple University in Philadelphia, PA with a B.A. in Journalism / Advertising.

Heather Dean

Heather Dean

National Head, Specialty Sales & Accounts, Takeda

Read more

Heather Dean is the National Head of Specialty Sales and Accounts at Takeda Pharmaceuticals USA, Inc. She is responsible for leading the Biologic Clinical Sales Specialist team as well as the Key Account Manager team charged with managing large, complex IBD accounts.

Heather’s pharmaceutical experience is focused in the areas of marketing and sales leadership. Her commercial brand leadership experience at Eli Lilly and Company, TAP Pharmaceuticals and Takeda includes the therapeutic categories of diabetes, CNS, metabolic disorders and GI. In addition to specialty sales leadership, Heather has also managed large sales forces in the general medicine arena.

William King

William King

Founder and Executive Chairman, Zephyr Health

Read more

William King is the founder and Executive Chairman of Zephyr Health; the Insights-as-a-Service leader harnessing the power of global health data to help Life Sciences companies engage the right physicians, accounts and institutions. He is passionate about creating innovative solutions to advance efficiency, strategy and tactical problem solving for Life Sciences companies

Under his leadership, Zephyr Health has grown to serve leading pharmaceutical, biotech, medical device and diagnostic companies globally. Zephyr has also received numerous industry accolades, including being named one of Gartner’s “Cool Vendors in Life Science,” PM360’s “Most Innovative Start-ups in 2015,” and Insights Success’ “20 Most Valuable Enterprise Big Data Companies.”

At multinational Johnson & Johnson, William held a range of global leadership positions in sales, marketing, training and strategy. He was also a member of the International Development Program for global leadership and people development.

William has participated in some of the industry’s most prestigious conferences including Big Data in BioMedicine, BIO International Convention and Digital Healthcare Innovation Summit. He speaks regularly on:

  • What you Need to Know About Creating a Big Data Strategy
  • Unfashionably Late to the Big Data Party: How Biopharma Can Catch Up
  • The Big Data Prescription for Pharma Marketing

William holds a Bachelor of Science in Business Administration from the University of Denver and serves on the American Heart Association Research Roundtable Executive Board. He currently resides in the Bay Area with his wife and two children.

Kim Murphy

Kim Murphy

VP, Global Vaccines Commercialization Leader, Influenza, GSK

Read more

Kim Murphy is Vice President and Global Vaccines Commercialization Leader for GSK’s Influenza Franchise. In this role, Kim leads GSK’s global influenza vaccines business and is accountable for both U.S. performance and the cross-functional Vaccines Commercialization Team, including global flu pandemic preparedness across vaccines and anti-virals.

A pharmaceutical industry and Vaccines veteran for more than 20 years, Kim recently led the North American integration of all commercial assets of Novartis Vaccines following GSK’s 2015 acquisition and spearheaded efforts to improve GSK Vaccines’ delivery of customer value, by running a 40-person US marketing and access team for the world’s largest vaccines manufacturer.

Christine Richards

Christine Richards

Director Quality Academy, Sanofi Pasteur

Read more

Christine (Chrissy) Richards currently serves as Director for the Sanofi Pasteur Quality Academy. As a formally trained Master's Degreed Chemist with a passion for people, Chrissy found success in the Sanofi Pasteur Quality Organization and is currently providing leadership and expertise in the development and deployment of Good Manufacturing and Distribution Practices training programs. Chrissy is a leader in the Sanofi Pasteur organizational transformation movement focused on reinventing the employee and leader relationship by engaging and empowering all individuals to achieve collective performance. This work has been recognized on a global scale by achieving the FICCI Quality Systems Excellence Award (2017), Outstanding Human Performance Improvement Award (2017), Organizational Culture Excellence Award (2016), Gold Quill Award (2016), and Employee Engagement Award (2016).

Robert P Draper

Robert P Draper

Sr Director, Lilly BioMedicines Forecasting, Eli Lilly and Company

Read more

Bob has 25 years of experience in forecasting and marketing analytics and for the last 20 years has been focused on the pharmaceutical industry. Bob began his career in finance, moved to marketing analytics consulting working across multiple business sectors in Europe. He joined Eli Lilly in Indianapolis where he has led the Global Forecasting team since 2000, and most recently leads the Biomedicines and Emerging Markets forecasting teams. His responsibilities include Strategic Planning, New Product forecasting, inline forecasting, business development and forecasting capabilities. Bob has an MA in Mathematics from the University of Oxford. He is a member of the advisory board for Kelley School of Business Analytics.

Roger Sawhney

Roger Sawhney

SVP Industry Strategy, Outcome Health

Read more

Senior Vice President of Life Sciences Strategy and Business Development

As senior vice president of life sciences strategy and business development, Roger leads Outcome Health's efforts to develop relationships and partnerships with the world’s leading life sciences companies. With 20 years of experience in the biopharmaceutical industry, Roger focuses on developing, coordinating and implementing strategies to help Outcome Health’s brand partners meet their business goals.

Roger was previously a partner in Bain and Company’s global healthcare and private equity practices, where he enabled healthcare companies to drive strategic position and competitive advantage. He also worked at Novartis as senior vice president and global head of corporate strategy, leading the company’s long range planning, business growth and eHealth efforts, as well as emerging market strategy. He serves on the Board of Directors for the New York Institute of Technology (NYIT).

John Gerow

John Gerow

Global Head, Customer Service Model, Ashfield

Read more

John is currently working with Ashfield as the Strategy Partner on the service team model. Prior to this John worked for 6 years in global commercial excellence with AstraZeneca and has extensive experience with New Commercial Models (NCM). John has pioneered many new capabilities, successfully launching pharma’s first service team model in 2008. He joined the Global Marketing and Sales group in 2010 as the Vice-President of Sales and New Channels, where he led the launch of NCM across 33 markets.

Previous experiences include: Sales, Sales management, Government Affairs Manager, Business Unit Director, Executive Director of Innovation as well as starting his own Marketing Agency. John holds an MBA from Ivey Business School, University of Western Ontario, Canada.

Laurie Cooke

Laurie Cooke

CEO, Healthcare Businesswomen's Association

Laurie Cooke is the CEO of Healthcare Businesswomen’s Association, a nonprofit with 50,000 members and 121 companies, dedicated to furthering the advancement and impact of women in healthcare. Laurie is a dedicated advocate for gender parity, speaker, thought leader, PharmaVOICE 100 most inspiring people in life sciences, and ASAE Mentor of the Year. Laurie served on PMI’s executive management team; on international teams in process improvement, team effectiveness, project management in pharma; and hospital pharmacist. Laurie graduated with a degree in Microbiology from U of MD, advanced scientific degree in Pharmacy from U of WA, masters in Software Engineering Management from U of Luton, England, licensed Pharmacist, and Certified Association Executive.

Mark Bard

Mark Bard

Founder, Digital Health Coalition

Read more

Mark Bard is a new media, marketing, and technology entrepreneur. In addition to personal ventures, he also invests in early stage technology and digital health startups taking an active advisory role with founders. With deep expertise in the digital health space, Mark’s focus and passion includes mobile, analytics, and customer service in a digital world. He previously sold Manhattan Research, a company he co-founded, to Providence Equity Partners. Mark co-founded the Digital Health Coalition, a non-profit think tank based in NYC, in 2011 and is actively involved in the continued growth of the organization.

Bob Kelly

Bob Kelly

Chairman, Sales Management Association

Robert J. (Bob) Kelly is chairman of The Sales Management Association (www.salesmanagement.org), a global, cross-industry association for sales management and sales operations. The Sales Management Association serves members in 50+ countries with research, conferences, and peer networking, and hosts the annual Sales Force Productivity Conference (www.salesmanagementconference.com).

Bob was previously vice president of sales operations and strategy at Genuine Parts Company, and worked in marketing strategy for MCI WorldCom. He teaches a sales management course to MBA students as an adjunct professor at Emory University’s Goizueta Business School’s in Atlanta.

Jill Donahue

Jill Donahue

Co-Founder, The Aurora Project

Jill Donahue believes there is an important role for pharma professionals in the pit crew surrounding the patient. As a consummate student, author and speaker on behavior change in healthcare, she helps pharma professionals learn how to become trusted, valued, influential partners to healthcare providers. She empowers them with a new way of selling and a system of what to say and do.

She is the author of EngageRx: The 3 Keys to Patient-focused Growth, founder of Excellerate and co-founder of The Aurora Project, a global group of pharma professionals united in their desire to illuminate the path to patient centricity.

Melva Covington

Melva Covington

Senior Director, Health Outcomes and Value Assessment, Pacira Pharmaceuticals

Dr. Covington joined Pacira Pharmaceuticals as Senior Director, Health Outcomes and Value Assessment, in February 2017. She has held leadership roles in R&D, Health Outcomes, Medical Affairs and Medical Operations at Sanofi (2010- 2017), Eli Lilly (2004-2010) and Roche Labs (2000-2004).

Her leadership and expertise are in public health, market access, strategic thinking, health outcomes and operations; and cover all levels of drug development and across therapeutic areas. Her work also focuses on reducing disparities in health outcomes and evaluating cultural competency.

She has degrees in Politics, Economics, Public Health, Education and Business. Melva has authored numerous publications and is an impassioned public speaker.

Felicia S. Johnson

Felicia S. Johnson

Patient Advocate

Read more

Felicia Johnson is an intentional woman with a purpose to fulfill. She was diagnosed with Stage IV breast cancer in 2003 and in 2010 with Triple Negative Cancer. She is a Speaker, Patient and Community Advocate. Her journey includes a family history of eleven women diagnosed with breast cancer over three generations. She knows the importance of patient participation during illness and survivorship. Felicia believes her strongest asset is her faith and passion to help others affected by cancer. Her goal is to empower through education. She volunteers at various cancer organizations and is an inspirational writer and blogger.

Speaker_Name

Nadim Yacteen

Partner, Management Consulting Practice, Clarkston Consulting

Read more

Nadim Yacteen is an associate partner in Clarkston Consulting’s management consulting practice. He brings over 25 years of experience in solving clients’ most strategic innovation challenges, having studied how successful companies innovate and developing a proprietary framework to realize innovative outcomes. Nadim has worked in various industry settings, both as an executive practitioner and trusted advisor. His experience in corporate, sales, and marketing strategies is backed by hands-on P&L management and field execution. He has led some of the world’s greatest brands through strategic innovation challenges to help them explore and define new markets, position and re-position winning brands, address competitive challenges, and respond to existential threats to their business models.

Prior joining Clarkston, Nadim served clients in the consumer products, life sciences, entertainment, and public sectors while with leading management consulting firms. His industry experience includes leadership positions with Johnson&Johnson, Novartis, and AEterna Zentaris, where he led regional brand franchises and served in global brand marketing, business development and sales capacities.

Nadim earned his Bachelor of Arts in Economics from the University of Massachusetts – Amherst. He also contributed to the design of the Innovation Consulting Lab at Columbia Business School, where he served as a guest lecturer and coach, by sharing his “real world innovation“ experience to help the MBA teams solve the business challenges of the Fortune 500 companies which participated in the Columbia innovation lab.

Jean McCoy

Jean McCoy

VP Strategy & Innovation, Health Advocacy Strategies

Read more

Jean McCoy is SVP of Strategy and Innovation at Health Advocacy Strategies, a patient engagement and technology firm that helps companies include the authentic voice of real patients in all aspects of their business. Jean has 25 years of biopharmaceutical commercialization experience and entrepreneurial business background. For more info: www.hastrategies.com.

Lise Hall

Lise Hall

Associate Director of Consumer Marketing Lung Cancer Franchise, AstraZeneca Pharmaceuticals

Read more

More information coming soon...

Dakar De La Cruz

Dakar De La Cruz

Senior Brand Manager Epilepsy, Patient Initiatives, UCB

Read more

More information coming soon...

Erik Cline

Erik Cline

Director Marketing US NeuroScience Business Unit, Shire

Read more

More information coming soon...

Sunny Verma

Sunny Verma

President and Founder, viihealth

Read more

Sunny Verma, President and Founder, viihealth is a seasoned Pharma executive with proven record in building and scaling innovative solutions to engage physicians and patients. Prior to founding viihealth, he held various critical commercial roles in a leading Pharmaceutical company, where he developed the US Human Health multi-channel strategy and was responsible for building / integrating digital channels. He pioneered integrated digital channel campaigns and built capabilities to improve customer experience and engagement. He holds a BA, Chemistry from Loyola University Chicago and an MBA from the University of Iowa. 

Mark Benthin

Mark Benthin

Executive Chairman, viihealth

Read more

Mark Benthin, Executive Chairman, viihealth is a serial entrepreneur with a proven record in delivering creative solutions involving cloud computing, data-centric applications, and mobile enterprise collaboration. Prior to viihealth, Mark founded Aptilon Corporation, where he developed the first remote physician detailing mobile solution for life sciences. As leader of commercial operations and business development, Mark was instrumental in growing the company and divesting that piece of the business. He is on the board of DMD Connects, a Health IT data company. BE, Computer Engineering from McMaster University.

Michael Schwartz

Michael Schwartz

Director of Product Marketing, Life Sciences, Salesforce

Read more

Michael Schwartz is Director of Product Marketing, Life Sciences at Salesforce. As part of the Healthcare and Life Sciences team, Michael works to bring customer success to biopharmaceutical, medical device, and diagnostic companies. He brings 15 years of industry experience ranging from medical devices to precision medicine. Before joining Salesforce, he was VP Marketing at Fluxion Biosciences, a company he co-founded to create precision oncology diagnostics based on circulating blood markers. He also held management and development positions at Advanced Stent Technologies (Acquired: Boston Scientific) and Biocardia. Michael received his MS from Columbia University and BS from UC Berkeley, both in Bioengineering.

Tony Romito

Tony Romito

Global Managing Director – Intelligent Patient Solutions, Accenture Life Sciences

Read more

Tony Romito is a Managing Director responsible for Accenture’s Global Intelligent Patient Solutions business with twenty years of industry experience across Biopharmaceuticals and Medical Products. In this role, he is responsible for bringing life sciences clients deep domain expertise through strategic, analytics and technology services to drive measurable value for patients. This includes the management of Accenture’s proprietary enterprise patient platform, as well as the network of strategic partners and the portfolio of investments in this arena.

Kate Knobil

Kate Knobil

Chief Medical Officer, Pharmaceuticals, GSK

Read more

Kate is the Chief Medical Officer for Pharmaceuticals at GSK. The mission of her group (Pharma Medical and Patient Safety) is to understand the current and future needs of patients, clinicians and healthcare systems to generate and communicate evidence that informs on the benefits, risks and overall value of GSK medicines.

Kirk Shepard

Kirk Shepard

President, Medical Affairs Professional Society & Senior Vice President, Head of Global Medical Affairs Oncology, Eisai Pharma

Read more

Dr. Kirk Shepard is the 2016-2017 President of the Medical Affairs Professional Society (MAPS) and has more than 25 years of experience in the pharmaceutical industry. He is a board-certified medical oncologist and hematologist physician. He is currently Senior Vice President, Head of Global Medical Affairs Oncology at Eisai Pharmaceutical Company.

Dr. Shepard’s experience in multiple therapeutic areas includes operational and strategic product development from Phases I through IV and the diverse disciplines of medical affairs and product commercialization, such as leading compliance and SOP/policy efforts, health economics & outcomes research & patient access, data generation, field-based medical teams (MSLs), PV/safety, medical communication & publications, patient advocacy, and public relations. In 2015, he was selected as one of the 100 Most Inspiring People in the Pharmaceutical Industry (PharmaVOICE).  Before his pharmaceutical career, Dr. Shepard served as a staff physician in the Department of Hematology and Medical Oncology at the Cleveland Clinic Foundation, where he supervised numerous studies in oncology and symptom control. He has more than 50 medical publications in journals and books.

Dr. Shepard earned his bachelor’s degree from Cornell University in Ithaca, NY, and his medical degree from the University of Cincinnati Medical School in Cincinnati, OH. He completed both his internship and residency in internal medicine at Case Western Reserve University in Cleveland, OH, and fellowships in hematology and oncology at the University of Chicago Hospitals and Clinics in Chicago, IL.

Alan Wright

Alan Wright

Chief Medical Officer, Roche Diagnostics

Read more

As the Chief Medical Officer for Roche Diagnostics Corporation, Alan serves as our clinical spokesperson and lead counsel on everything from the policy to the practice of diagnostic medicine. With his extensive history in the managed care, pharmaceutical and biotechnology industries, Alan is well-versed in the changing landscape of healthcare including emerging trends and technologies, regulatory and legislative hurdles, payer challenges and the growing relevance of diagnostics with the advent of outcome-based reimbursement.

Alan brings with him medical and scientific leadership experience from his work from a variet. He earned his medical degree from University of Pennsylvania School of Medicine and a masters of public health degree from Johns Hopkins School of Public Health and Hygiene.

Shontelle Dodson

Shontelle Dodson

Vice President, Medical Excellence/Medical Affairs Global, Astellas

Read more

Dr. Shontelle Dodson is Vice President, Medical Excellence within the Global Medical Affairs organization at Astellas Pharma and has extensive clinical and research experience in the healthcare and pharmaceutical industries. After several years of service in direct patient care at the Department of Veterans Affairs, Shontelle spent 11 years at Pfizer, Inc. in various Medical Affairs leadership roles across the Urology and Respiratory franchises. Following her work with Pfizer, she served as Vice President, Medical Affairs at GTx, Inc. In this capacity Shontelle led the Phase 3 clinical development of a selective androgen receptor modulator for the prevention and treatment of muscle wasting in patients with cancer including incorporating key economic and health outcomes assessments to support product utilization and valuation. Under her leadership at Astellas, the Medical Affairs group has pioneered multiple, innovative real world data projects including two national registries in prostate cancer and overactive bladder, as well as partnered research with leading managed care and academic organizations.

Shontelle has received multiple awards for leadership and innovation during her career, including the National Healthcare Business Women’s Association Rising Star and Astellas Vision Award. Dr. Dodson holds a Doctor of Pharmacy degree from Mercer University School of Pharmacy and completed a postdoctoral residency at the Department of Veterans Affairs Medical Center in Nashville, Tennessee.

Rosh Dias

Rosh Dias

Vice President, Global Scientific Affairs, Amgen

Read more

Rosh Dias, M.D., MRCP, is a UK trained physician with 17 year’s industry experience in a set of functionally and geographically diverse Medical Affairs roles in both large pharma and biotech.

Currently serving as Vice President of Global Scientific Affairs at Amgen, he leads global and regional organizations responsible for Scientific Communications, Medical Writing, and Medical Science Liaisons across all Amgen therapeutic areas.

Rosh has had prior roles at Onyx Pharmaceuticals, and Novartis Oncology, where he has led Global Medical Affairs programs for key compounds, Country Medical Organizations, and Field Medical Organizations.

Paul Rowe

Paul Rowe

Vice President, Global Medical Affairs Head, Airway/Respiratory, Sanofi Genzyme

Read more

Dr. Rowe has well over a decade of research experience spanning from pre-clinical to late phase drug development programs, primarily in respiratory (and cardiovascular) medicine. He has been directly responsible for medical strategy and lifecycle management of several Chronic Obstructive Pulmonary Disease (COPD), asthma, and cardiovascular medicines. Dr. Rowe has been successfully involved in achieving New Drug Application (NDA) approvals for first in therapeutic class respiratory products and also has led various clinical development global projects from phase II through phase IV clinical trials. He has authored and co-authored several publications in respiratory medicine (COPD-focused, and is a frequent lecturer and speaker at professional society meetings, and educational forums. Dr. Rowe holds degrees from Harvard University and the University of Rochester School of Medicine, and certifications from the London School of Economics and Villanova University.

Dr. Rowe is an active member of several national and international societies and he recently served as Vice Chair of the Drug, Device, Discovery, and Development Committee of the American Thoracic Society (ATS). He has a primary interest in promoting international medical research collaboration and innovation across government, academia, and industry.

In his current role, Dr. Rowe is responsible for building and leading a Global Medical Affairs team and strategy within the respiratory space for several novel compounds in mid and late stage development, in various therapeutic indications.

Stanislav Glezer

Stanislav Glezer

former Vice President, Medical Affairs, Novo Nordisk

Read more

Stan Glezer, MD, MBA is an industry physician, passionate in optimizing value of phamecutical innovation for the patients, through partnering with the healthcare system.

Until recently, he served as Vice President of US Medical Affairs at Novo Nordisk Inc. Prior to joining Novo Nordisk, Stan has worked at Sanofi where, most recently, he led the development, regulatory submission, and launch preparation of Toujeo.

He brings with him extensive knowledge of medical affairs at an affiliate and Global level, as well as of the commercial areas of pharmacueitcal business and has held leadership roles in post-marketing research, epidemiology, medical information, medical communications, HEOR, interfacing with regulatory agencies, market access, and overall lifecycle management

Although his activities in the past few years were predominatly focused on diabetes, Stan has worked in multiple theraputic areas, including osteoporosis, oncology, immuno-inflammation, obesity, thrombosis, bleeding disorder and rare diseases. HE has a strong track record of leading the teams in establishing collaborations with healthcare providers, key opinion leaders, payers, and professional associations.

Stan received his medical training in Russia and has worked in Canada and in France for the past 20 years. He has an MBA from California Coast University and completed his graduate work in Clinical Research at McGill University.

Dana Evans

Dana Evans

Director for Patient Access, Collaboration and Exchange, Genentech

Read more

Dana Evans is the Director for Patient Access, Collaboration and Exchange with Genentech Medical Affairs. Dr. Evans manages a team of clinicians that provides scientific, clinical and managed care professional support to account teams who are responsible for payers, hospitals, government programs, group purchasing organizations and product distribution companies.

Dr. Evans obtained his medical degree from the University of Texas Medical School at Houston and completed his residency in Family Medicine at Southwest Memorial Hospital in Houston. He practiced family medicine in Texas, including obstetrics and surgery, for seven years. In 1992, he left clinical practice to begin a career in administrative medicine. His resume includes positions as medical director, chief medical officer and executive officer for regional and national health plans. He has also been a managed care consultant for health plans and physician organizations. He moved to the pharmaceutical industry as a medical director for managed care with GlaxoSmithKline in 2001. Dr. Evans joined Genentech in 2008 as a medical director for Value Based Healthcare.

Lav (Bobby) Parvathenani

Lav (Bobby) Parvathenani

Specialty Medical Information Lead, US Medical, Bristol-Myers Squibb

Read more

More information coming soon...

Diane McDowell

Diane McDowell

Head, Global Scientific Affairs Oncology, GSK

Read more

Diane McDowell recently returned to GlaxoSmithKline with over ten years of industry experience. Diane is a fellowship trained, board certified, surgical oncologist. She is also an award winning, pharmaceutical executive with oncology and immuno-oncology experience in both clinical development and medical affairs. Diane’s work has spanned both US and international markets for Bristol-Myers Squibb, GlaxoSmithKline, and Merck. Diane’s clinical development experience includes indication file lead and regulatory interaction. Her Medical Affairs experience includes building and leading large teams, medical matrix team creation and management, Phase IV study leadership and Investigator Sponsored Study Program leadership.

Prior to joining industry Diane was in clinical practice as a general and breast cancer surgeon. Diane completed her fellowship training at Fox Chase Cancer Center, and her surgery residency at Tulane University and Charity Hospital in New Orleans. Her industry career started at BMS in 2007 where she spent over 5 years in various roles. Starting as US medical lead for Ixempra in breast cancer, and expanding into other roles including a regional role in the EU launch of Yervoy in melanoma, Medical Affairs lead for the Imclone/BMS lung cancer initiatives involving Necitumumab, and medical monitor for both lung and melanoma ipilimumab trials. In her capacity on the Yervoy team, she was involved in the Yervoy safety management training and education of her peers as well as external investigators.

In 2013, she joined GSK as an Executive Director, Medical Affairs Lead for Tafinlar/Mekinist where she created and implemented a plan for successful launch of Tafinlar/Mekinist into the U.S. Market. She led cross functional collaboration to develop and execute the USMA plan for combination therapy, led Phase IV studies, and served as medical point person for external communication and advocacy groups. In 2015, Diane was asked to lead US Oncology Global Medical Affairs at Merck. While there, Diane built a team of over forty-five people to support the growing Keytruda franchise.

Roslyn Schneider

Roslyn Schneider

Global Patient Affairs Lead, Pfizer

Read more

Roz is the Global Patient Affairs (GPA) Lead within Pfizer’s Chief Medical Office. Roz’s team drives more systematic, end to end patient centricity at Pfizer. She received her BS from the Sophie Davis School of Biomedical Education of the City College of New York, MD from Mount Sinai School of Medicine, and MSc in Pharmaceutical Medicine from Hibernia College. A retired Clinical Professor of Medicine of Albert Einstein College of Medicine, an Internist, Pulmonologist, Intensivist, she practiced for twenty years. She published in the areas of pulmonary complications of HIV infection, venous thromboembolic disease, medical ethics and medical education.

Karen Lowney

Karen Lowney

Executive Director, Global Compliance, Privacy & Transparency, Astellas

Read more

Karen Lowney is the Executive Director, Global Compliance, Privacy & Transparency at Astellas Pharma, where she is responsible for providing compliance support to Global functions, including Development, Medical Affairs and Marketing Strategy. She is responsible for Transparency Reporting as well as managing systems and processes that govern various interactions with healthcare professionals and healthcare organizations. She also serves as the Americas Privacy Officer.

Prior to Astellas, Karen was the Senior Director of Global Compliance at Cephalon, where she managed compliance across business units including the development, implementation and oversight of policies, procedures and processes, employee training, aggregate spend tracking and government reporting, monitoring, incident management and investigations, and providing day-to-day advice to business partners.

Karen previously served as the Director of International Compliance at Schering-Plough where she was responsible for implementation of compliance initiatives within the Global Pharmaceutical Business, coordination of their compliance officer network, and ensuring policies, procedures and processes adhered to corporate guidelines as well as local laws, codes and regulations.

She holds a B.S.B.A in Accounting from the University of Missouri and is a Certified Internal Auditor.

Leonard Friedland

Leonard Friedland

Vice President, Director Scientific Affairs and Public Policy, Vaccines North America, GSK

Read more

Dr. Leonard Friedland is Vice President, Director Scientific Affairs and Public Health, Vaccines North America at GSK. He is also a licensed pediatrician in the state of Pennsylvania. Dr. Friedland has held many positions in clinical research and development with GSK since 2003, specializing in infectious disease vaccination.

Prior to his work at GSK, Dr. Friedland was Division Chief, Pediatric Emergency Medicine at Temple University School of Medicine. Dr. Friedland studied medicine at Mount Sinai School of Medicine in New York and conducted his residency in pediatrics at the Children's Hospital of Philadelphia and his fellowship in pediatric emergency medicine at St. Christopher's Hospital for Children, also in Philadelphia.

He is currently a fellow and active member of the American Academy of Pediatrics and has published over 39 peer reviewed articles during his career.

Janet Baldwin

Janet Baldwin

Vice President, Real World and Late Phase, INC Research

Read more

Janet Baldwin has over 30 years of drug development experience, working for both large pharma and clinical research organizations. She has a B.S. in Biochemistry and began her career as an analytical chemist developing and validating methods for detection of new drug entities in the pre-clinical and clinical pharmacology settings. Her responsibilities included the development of an analytical lab in support of the bioanalytical group at Hoffmann – La Roche. Janet then became a Clinical Research Associate where she developed protocols, CRFs and recruited and managed sites for multiple phase II and III studies. Her career progressed to clinical study/trial management and then department management. Janet has built and lead departments across a number of functional areas including, project management, analytics, clinical research, feasibility, site identification and patient recruitment. For the past 10 years Janet has focused on Late Phase Research. While at Quintiles, Janet was the Americas Head of Late Phase Project Management and Analytics, designing and overseeing Observational (both prospective and retrospective), phase IV interventional, large Outcomes Studies and Expanded Access Programs (EAPs). Her experience also includes serving as a principal investigator for an observational study where patients were recruited using pharmacy data. As Global Head of Clinical Operations, Observational Research at PAREXEL, she created a clinical team for the purpose of providing site management support for observational studies. Janet is currently Vice President for Real World and Late Phase at INC Research.

Elizabeth Engelhardt

Elizabeth Engelhardt

Head of Specialty Strategy & Clinical Management, Aetna

Read more

Elizabeth Engelhardt is the Head of Specialty Strategy and Clinical Management Programs for Aetna Pharmacy Management. In this role Ms. Engelhardt is accountable for the development, design and execution of clinically sound, cost conscious Specialty medical and pharmacy pharmaceutical management for Aetna Commercial members. Prior to her current role, Ms. Engelhardt was the Director of Trade Relations for Aetna Pharmacy Management, accountable for setting strategic plans for Aetna’s relationships with Pharmaceutical Manufacturers, managing a portfolio of rebate contracts and creating and maintaining valuable partnerships within the manufacturer community. She joined Aetna in 2011.

In addition to her Aetna experience, Ms. Engelhardt held management positions within the health care industry with various companies including Novartis Oncology, BioScrip, Inc, Teva Pharmaceuticals and Merck. Her clinical experience includes Pediatric Nursing, Pediatric Oncology Nursing, Adult Oncology Nursing and Nurse Management.

She holds a Bachelor of Science degree in Nursing from Molloy College, Rockville Center, NY.

Soumi Saha

Soumi Saha

Assistant Director of Pharmacy & Regulatory Affairs, Academy of Managed Care Pharmacy (AMCP)

Read more

Soumi Saha serves as the Assistant Director of Pharmacy & Regulatory Affairs at the Academy of Managed Care Pharmacy (AMCP). Soumi joined AMCP in July 2015 and is responsible for advancing the interests of its members by advocating the Academy’s regulatory positions at the federal and state level. Prior to joining AMCP, Soumi worked for Kaiser Permanente where she held various positions and most recently served as the Director of National Pharmacy Controls. Soumi has a Doctor of Pharmacy (PharmD) from the University of Maryland School of Pharmacy and a Juris Doctor (JD) with a concentration in Health Law from the University of Maryland School of Law.

Patrick Reilly

Patrick Reilly

CEO, phactMI

Read more

Patrick Reilly is currently CEO for phactMITM, a collaboration of pharmaceutical company Medical Information (MI) departments that are dedicated to supporting healthcare professionals in their commitment to provide quality patient care. Patrick is also principal at Reilly Consulting, LLC, focusing on pharmaceutical medical affairs management.

Patrick has spent the past 30 years within the Pharmaceutical Industry, primarily at Bristol Myers Squibb within the R&D/Medical Affairs organization. During his tenure at BMS, Patrick worked in a variety of leadership roles with a focus on building and enhancing organizational capabilities like clinical trial monitoring, global field medical, and most recently globalizing medical information.

As Vice President of Medical Information at BMS he led the globalization of the organization, leveraging technology and establishing innovative multi-channels to enhance the exchange of medical and scientific information for HCPs. Patrick was also actively involved in the people strategy at BMS, talent acquisition and development, where he was the executive sponsor of the PharmD Fellowship/Residency program.

Patrick has a bachelor’s degree in Biology, a bachelor’s degree in Medical Science (as a Physician Assistant) and a Master’s Degree in Business administration. He is an active member of the Drug Information Association (DIA) and the American Society of Association Executives (ASAE) and is a frequent presenter at Life Sciences conferences.

Lynn Vos

Lynn Vos

CEO, ghg | greyhealth group

Read more

More information coming soon...

Joe Kohles

Joe Kohles

Chief Medical Officer, Envision Pharma Group

Read more

More information coming soon...

Honorio Silva

Honorio Silva

President, IFAPP (International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine)

Read more

Dr. Silva’s professional career has focused on fostering clinical research and medical education with focus on emerging countries, in addition to serving the pharmaceutical industry, academia and various professional associations. After 30-years of service with Pfizer Inc, Dr. Silva retired as Vice President, Science and Medical Professional Development, within the External Medical Affairs group. He also served as Vice President, Medical and Regulatory Affairs, Japan, Asia, Africa & Latin America and Director/Team Leader Medical Operations, Latin America & Canada. He was also Assistant Professor of Clinical Pharmacology at the Universidad Central de Venezuela Medical School.

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription